Document:

Exhibit
10.1

 

$350,000,000

 

FUBOTV
INC.

 

3.25%
CONVERTIBLE SENIOR NOTES DUE 2026

 

PURCHASE
AGREEMENT

 

January
28, 2021

 

    	 

    	 

    

 

January
28, 2021

Evercore
Group L.L.C.

 

	c/o	Evercore Group L.L.C.
		55 East 52nd Street
		New York, New York 10055

 

Ladies
and Gentlemen:

 

fuboTV
Inc., a Florida corporation (the “Company”), proposes to issue and sell to the several purchasers named in
Schedule I hereto (the “Initial Purchasers”), for whom Evercore Group L.L.C. is acting as representative (the
“Representative” or “you”), $350,000,000 principal amount of its 3.25% Convertible Senior
Notes due 2026 (the “Firm Securities”) to be issued pursuant to the provisions of an Indenture dated as of
February 2, 2021 (the “Indenture”) between the Company and U.S. Bank National Association, as Trustee (the
“Trustee”). The Company also proposes to issue and sell to the Initial Purchasers not more than an additional
$52,500,000 principal amount of its 3.25% Convertible Senior Notes due 2026 (the “Additional Securities”) if
and to the extent that you, as Representative, shall have determined to exercise, on behalf of the Initial Purchasers, the right
to purchase such 3.25% Convertible Senior Notes due 2026 granted to the Initial Purchasers in Section 2 hereof. The Firm Securities
and the Additional Securities are hereinafter collectively referred to as the “Securities”. The Securities
will be convertible into cash, shares (the “Underlying Securities”) of the Company’s common stock, par
value $0.001 per share (the “Common Stock”) or a combination of cash and Underlying Securities, at the Company’s
election.

 

The
Securities and the Underlying Securities will be offered without being registered under the Securities Act of 1933, as amended
(the “Securities Act”), to qualified institutional buyers (“QIBs”) in compliance with the
exemption from registration provided by Rule 144A under the Securities Act.

 

In
connection with the sale of the Securities, the Company has prepared a preliminary offering memorandum (the “Preliminary
Memorandum”) and will prepare a final offering memorandum (the “Final Memorandum”) including or incorporating
by reference a description of the terms of the Securities and the Underlying Securities, the terms of the offering and a description
of the Company. For purposes of this Purchase Agreement (this “Agreement”), “Additional Written Offering
Communication” means any written communication (as defined in Rule 405 under the Securities Act) that constitutes an
offer to sell or a solicitation of an offer to buy the Securities other than the Preliminary Memorandum or the Final Memorandum;
“Time of Sale Memorandum” means the Preliminary Memorandum together with each Additional Written Offering Communication
or other information, if any, each identified in Schedule II hereto under the caption Time of Sale Memorandum; and “General
Solicitation” means any offer to sell or solicitation of an offer to buy the Securities by any form of general solicitation
or advertising (as those terms are used in Regulation D under the Securities Act). As used herein, the terms Preliminary Memorandum,
Time of Sale Memorandum and Final Memorandum shall include the documents, if any, incorporated by reference therein on the date
hereof. The terms “supplement”, “amendment” and “amend” as used herein
with respect to the Preliminary Memorandum, the Time of Sale Memorandum, the Final Memorandum or any Additional Written Offering
Communication shall include all documents subsequently filed by the Company with the Securities and Exchange Commission (the “Commission”)
pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are deemed to be incorporated
by reference therein.

 

    	 

    	 

    

 

1. Representations
and Warranties. The Company represents and warrants to, and agrees with, the Representative that:

 

(a)
Each document, if any, filed or to be filed pursuant to the Exchange Act and incorporated by reference in the Preliminary Memorandum,
the Time of Sale Memorandum or the Final Memorandum complied or will comply when so filed in all material respects with the Exchange
Act and the applicable rules and regulations of the Commission thereunder, the Time of Sale Memorandum does not, and at the time
of each sale of the Securities in connection with the offering when the Final Memorandum is not yet available to prospective purchasers
and at the Closing Date (as defined in Section ‎4), the Time of Sale Memorandum, as then amended or supplemented by
the Company, if applicable, will not, contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements therein, in the light of the circumstances under which they were made, not misleading, any Additional Written
Offering Communication prepared, used or referred to by the Company, when considered together with the Time of Sale Memorandum,
at the time of its use did not contain any untrue statement of a material fact or omit to state a material fact necessary to make
the statements therein, in the light of the circumstances under which they were made, not misleading, any General Solicitation
that is not an Additional Written Offering Communication, made by the Company or by the Initial Purchaser with the consent of
the Company, when considered together with the Time of Sale Memorandum, at the time when made or used did not contain any untrue
statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading and the Preliminary Memorandum does not contain and the Final Memorandum, in the form
used by the Initial Purchasers to confirm sales and on the Closing Date (as defined in Section 4), will not contain any untrue
statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading, except that the representations and warranties set forth in this paragraph do not
apply to statements or omissions in the Preliminary Memorandum, the Time of Sale Memorandum, the Final Memorandum, Additional
Written Offering Communication or General Solicitation based upon information relating to any Initial Purchaser furnished to the
Company in writing by such Initial Purchaser through the Representative expressly for use therein.

 

    	2

    	 

    

 

(b) Except
for the Additional Written Offering Communications, if any, identified in Schedule II hereto, including electronic road shows,
if any, furnished to the Representative before first use, the Company has not prepared, used or referred to, and will not, without
the Representative’s prior consent, prepare, use or refer to, any Additional Written Offering Communication.

 

(c) The
Company has been duly incorporated and is validly existing as a corporation in good standing under the laws of the jurisdiction
of its incorporation and has the corporate power and authority to own, lease and operate its properties and to conduct its business
as described in the Preliminary Memorandum, the Time of Sale Memorandum and the Final Memorandum, and to enter into and perform
its obligations under this Agreement. The Company is duly qualified as a foreign corporation to transact business and is in good
standing in each jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property
or the conduct of business, except where the failure to qualify or to be in good standing could not reasonably be expected to
result in a Material Adverse Change (as defined below).

 

(d) Each
of the Company’s “subsidiaries” (for purposes of this Agreement, as defined in Rule 405 under the Securities
Act) has been duly incorporated or organized, as the case may be, and is validly existing as a corporation, partnership or limited
liability company, as applicable, in good standing under the laws of the jurisdiction of its incorporation or organization and
has the power and authority (corporate or other) to own, lease and operate its properties and to conduct its business as described
in the Preliminary Memorandum, the Time of Sale Memorandum and the Final Memorandum, except where the failure to be in good standing
could not reasonably be expected to result in a Material Adverse Change. Each of the Company’s subsidiaries is duly qualified
as a foreign corporation, partnership or limited liability company, as applicable, to transact business and is in good standing
in each jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the
conduct of business, except where the failure to qualify or to be in good standing could not reasonably be expected to result
in a Material Adverse Change. Except as otherwise disclosed in the Preliminary Memorandum, the Time of Sale Memorandum and the
Final Memorandum, all of the issued and outstanding capital stock or other equity or ownership interests of each of the Company’s
subsidiaries have been duly authorized and validly issued, are fully paid and nonassessable and are owned by the Company, directly
or through subsidiaries, free and clear of any security interest, mortgage, pledge, lien, encumbrance or adverse claim. None of
the outstanding capital stock or equity interest in any subsidiary was issued in violation of preemptive or similar rights of
any security holder of such subsidiary. The constitutive or organizational documents of each of the subsidiaries comply in all
material respects with the requirements of applicable laws of its jurisdiction of incorporation or organization and are in full
force and effect. The only subsidiaries of the Company are (i) fuboTV Media Inc., a Delaware corporation, and (ii) certain other
subsidiaries which, considered in the aggregate as a single subsidiary, do not constitute a significant subsidiary (as such term
is defined in Rule 1-02 of Regulation S-X).

 

    	3

    	 

    

 

(e) This
Agreement has been duly authorized, executed and delivered by the Company.

 

(f) The
authorized, issued and outstanding capital stock of the Company is as set forth in the Preliminary Memorandum, the Time of Sale
Memorandum and the Final Memorandum (including under the caption “Capitalization”) (other than for subsequent issuances,
if any, pursuant to employee benefit plans, or upon the exercise of outstanding options or warrants, in each case as described
in the Preliminary Memorandum, the Time of Sale Memorandum and the Final Memorandum). The Securities and the Company’s capital
stock conforms in all material respects to the description thereof contained in the Time of Sale Memorandum. All of the issued
and outstanding capital stock of the Company has been duly authorized and validly issued, is fully paid and nonassessable and
has been issued in compliance with all federal and state securities laws. None of the outstanding capital stock was issued in
violation of any preemptive rights, rights of first refusal or other similar rights to subscribe for or purchase securities of
the Company. There are no authorized or outstanding options, warrants, preemptive rights, rights of first refusal or other rights
to purchase, or equity or debt securities convertible into or exchangeable or exercisable for, any capital stock of the Company
or any of its subsidiaries other than those described in the Preliminary Memorandum, the Time of Sale Memorandum and the Final
Memorandum. The descriptions of the Company’s stock option and other stock plans or arrangements, and the options or other
rights granted thereunder, set forth in the Preliminary Memorandum, the Time of Sale Memorandum and the Final Memorandum in all
material respects accurately and fairly presents the information required to be shown with respect to such plans, arrangements,
options and rights.

 

(g) The
Securities have been duly authorized and, when executed and authenticated in accordance with the provisions of the Indenture and
delivered to and paid for by the Initial Purchasers in accordance with the terms of this Agreement, will be valid and binding
obligations of the Company, enforceable in accordance with their terms, subject to the effects of (i) bankruptcy, insolvency,
fraudulent conveyance, fraudulent transfer, reorganization, moratorium or other similar laws relating to or affecting the rights
or remedies of creditors generally, (ii) the application of general principles of equity (including, without limitation, concepts
of materiality, reasonableness, good faith and fair dealing, regardless of whether enforcement is considered in proceedings at
law or in equity), and (iii) applicable law and public policy with respect to rights to indemnity and contribution) (together,
the “Enforceability Exceptions”), and will be entitled to the benefits of the Indenture pursuant to which such
Securities are to be issued.

 

    	4

    	 

    

 

(h) The
execution, authentication, issuance and sale of the Securities are not subject to any preemptive rights, rights of first refusal
or other similar rights to subscribe for or purchase the Securities that have not been validly waived. There are no persons with
rights to have any equity or debt securities included in the offering contemplated by this Agreement that have not validly waived
such rights.

 

(i)
A number of shares of Common Stock equal to the maximum number of shares of Underlying Securities (including the maximum number
of additional shares of Underlying Securities by which the Conversion Rate (as such term is defined in the Indenture) may be increased
upon conversion in connection with a Make-Whole Fundamental Change (as such term is defined in the Indenture) and assuming (x)
the Company elects, upon each conversion of the Securities, to deliver solely shares of Common Stock, other than cash in lieu
of any fractional shares, in settlement of each such conversion and (y) the Representative exercises its option to purchase the
Additional Securities in full (the “Maximum Number of Underlying Securities”)) have been duly authorized and
reserved and, when issued upon conversion of the Securities in accordance with the terms of the Securities, will be validly issued,
fully paid and non-assessable, and the issuance of the Underlying Securities will not be subject to any preemptive or similar
rights.

 

(j) The
Indenture has been duly authorized and, when executed and delivered by the Company, and, assuming due execution and delivery thereof
by the Trustee, the Indenture will constitute a valid and binding agreement of, the Company, enforceable in accordance with its
terms, subject to the effects of the Enforceability Exceptions.

 

(k) The
execution and delivery by the Company of, and the performance by the Company of its obligations under, this Agreement, the Indenture,
the Securities (including the issuance of the Underlying Securities upon conversion thereof) (together, the “Transaction
Documents”) will not contravene any provision of (i) applicable law, (ii) the certificate of incorporation or by-laws
of the Company, (iii) any agreement or other instrument binding upon the Company or any of its subsidiaries that is material to
the Company and its subsidiaries, taken as a whole, or (iv) any judgment, order or decree of any governmental body, agency or
court having jurisdiction over the Company or any subsidiary, except that in the case of clauses (i), (iii) and (iv) above, where
such contravention would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Change, or on
the power or ability of the Company to perform its obligations under this Agreement; and no consent, approval, authorization or
order of, or qualification with, any governmental body or agency is required for the performance by the Company of its obligations
under the Transaction Documents, except such as has been previously obtained and may be required by the securities or Blue Sky
laws of the various states in connection with the offer and sale of the Securities.

 

    	5

    	 

    

 

(l) (i)
There has been no material adverse change, or any development that could be expected to result in a material adverse change, from
that set forth in the Preliminary Memorandum, the Time of Sale Memorandum, or the Final Memorandum, respectively, in (A) the condition,
financial or otherwise, or in the earnings, business, operations, operating results, assets, liabilities or prospects, whether
or not arising from transactions in the ordinary course of business, of the Company and its subsidiaries, considered as one entity
or (B) the ability of the Company to consummate the transactions contemplated by this Agreement or perform its obligations hereunder
(any such change being referred to herein as a “Material Adverse Change”); (ii) subsequent to the respective
dates as of which information is given in each of the Preliminary Memorandum, the Time of Sale Memorandum, and the Final Memorandum,
the Company and its subsidiaries, considered as one entity, have not incurred any material liability or obligation, indirect,
direct or contingent, including without limitation any losses or interference with their business from fire, explosion, flood,
earthquakes, accident or other calamity, whether or not covered by insurance, or from any strike, labor dispute or court or governmental
action, order or decree, that are material, individually or in the aggregate, to the Company and its subsidiaries, considered
as one entity, and have not entered into any material transactions; and (iii) subsequent to the respective dates as of which information
is given in each of the Preliminary Memorandum, the Time of Sale Memorandum, and the Final Memorandum, there has not been any
material decrease in the capital stock or any material increase in any short-term or long-term indebtedness of the Company or
its subsidiaries and there has been no dividend or distribution of any kind declared, paid or made by the Company or, except for
dividends paid to the Company or its subsidiaries, by any of the Company’s subsidiaries on any class of capital stock, or
any repurchase or redemption by the Company or any of its subsidiaries of any class of capital stock.

 

    	6

    	 

    

 

(m) Neither
the Company, nor any of its subsidiaries is (i) in violation of its charter or by-laws, partnership agreement or operating agreement
or similar organizational documents, as applicable, or (ii) is in default (or, with the giving of notice or lapse of time, would
be in default) (“Default”) under any indenture, loan, credit agreement, note, lease, license agreement, contract,
franchise or other instrument (including, without limitation, any pledge agreement, security agreement, mortgage or other instrument
or agreement evidencing, guaranteeing, securing or relating to indebtedness) to which the Company or any of its subsidiaries is
a party or by which it or any of them may be bound, or to which any of their respective properties or assets are subject (each,
an “Existing Instrument”), except in the case of this clause (ii) for such Defaults (other than Defaults under
Specified Debt Instruments (as defined below)) as could not reasonably be expected, individually or in the aggregate, to result
in a Material Adverse Change. The Company’s execution, delivery and performance of this Agreement, consummation of the transactions
contemplated hereby and by the Preliminary Memorandum, the Time of Sale Memorandum and the Final Memorandum and the execution,
authentication, issuance and sale of the Securities (including the use of proceeds from the sale of the Securities as described
in the Preliminary Memorandum, the Time of Sale Memorandum and the Final Memorandum under the caption “Use of Proceeds”)
(i) have been duly authorized by all necessary corporate action and will not result in any violation of the provisions of the
charter or by-laws, partnership agreement or operating agreement or similar organizational documents, as applicable, of the Company,
or any of its subsidiaries, (ii) will not conflict with or constitute a breach of, or Default or a Debt Repayment Triggering Event
(as defined below) under, or result in the creation or imposition of any lien, charge or encumbrance upon any property or assets
of the Company, or any of its subsidiaries pursuant to, or require the consent of any other party to, any Existing Instrument,
except, with respect to this clause (ii), as otherwise disclosed in the Preliminary Memorandum, the Time of Sale Memorandum and
the Final Memorandum, and (iii) will not result in any violation of any law, administrative regulation or administrative or court
decree applicable to the Company, or any of its subsidiaries, except, with respect to this clause (iii), the Preliminary Memorandum,
the Time of Sale Memorandum and the Final Memorandum. As of the date hereof, no Debt Repayment Triggering Event exists under any
Specified Debt Instrument. No consent, approval, authorization or other order of, or registration or filing with, any court or
other governmental or regulatory authority or agency, is required for the Company’s execution, delivery and performance
of this Agreement and consummation of the transactions contemplated hereby and by the Preliminary Memorandum, the Time of Sale
Memorandum and the Final Memorandum, except such as have been obtained or made by the Company and are in full force and effect
under the Securities Act and such as may be required under applicable state securities or blue sky laws or the Financial Industry
Regulatory Authority, Inc. (“FINRA”). As used herein, (x) a “Debt Repayment Triggering Event”
means any event or condition which gives, or with the giving of notice or lapse of time would give, the holder of any note, debenture
or other evidence of indebtedness (or any person acting on such holder’s behalf) the right to require the repurchase, redemption
or repayment of all or a portion of such indebtedness by the Company or any of its subsidiaries and (y) a “Specified
Debt Instrument” means each of the following Existing Instruments: (a) that certain Credit Agreement dated as of July
16, 2020 by and among the Company and fuboTV Inc., as Borrowers, and Access Road Capital LLC as Lender, (b) that certain Credit
and Guaranty Agreement dated as of April 6, 2018, by and among fuboTV Inc., as borrower, AMC Networks Ventures LLC, as administrative
Agent and the other parties thereto from time to time (as amended), (c) that certain promissory note issued by Pulse Evolution
Corporation to Cam Digital LLC, on April 15, 2016 (as amended) and (d) that certain loan outstanding to fuboTV Inc. from JPMorgan
Chase Bank, N.A., under the SBA Paycheck Protection Program dated as of April 21, 2020.

 

    	7

    	 

    

 

(n) The
Company and its subsidiaries have been and are in compliance with all applicable laws, rules and regulations, except where failure
to be so in compliance could not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Change.

 

(o) There
is no action, suit, proceeding, inquiry or investigation brought by or before any legal or governmental entity now pending or,
to the knowledge of the Company, threatened, against or affecting the Company or any of its subsidiaries, which could reasonably
be expected, individually or in the aggregate, to result in a Material Adverse Change. Except as would not reasonably be expected,
individually or in the aggregate, to result in a Material Adverse Change, (i) no labor dispute with the employees of the Company
or any of its subsidiaries, or with the employees of any principal supplier, manufacturer, customer or contractor of the Company,
exists or, (ii) to the knowledge of the Company, is threatened or imminent.

 

(p) Except
as could not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Change: (i) neither the
Company nor any of its subsidiaries is in violation of any federal, state, local or foreign statute, law, rule, regulation, ordinance,
code, policy or rule of common law or any judicial or administrative interpretation thereof, including any judicial or administrative
order, consent, decree or judgment, relating to pollution or protection of human health, the environment (including, without limitation,
ambient air, surface water, groundwater, land surface or subsurface strata) or wildlife, including, without limitation, laws and
regulations relating to the release or threatened release of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous
substances, petroleum or petroleum products (collectively, “Hazardous Materials”) or to the manufacture, processing,
distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials (collectively, “Environmental
Laws”); (ii) the Company and its subsidiaries have all permits, authorizations and approvals required under any applicable
Environmental Laws and are each in compliance with their requirements; (iii) there are no pending or, to the Company’s knowledge,
threatened administrative, regulatory or judicial actions, suits, demands, demand letters, claims, liens, notices of noncompliance
or violation, investigation or proceedings relating to any Environmental Law against the Company or any of its subsidiaries; and
(iv) to the Company’s knowledge, there are no events or circumstances that might reasonably be expected to form the basis
of an order for clean-up or remediation, or an action, suit or proceeding by any private party or governmental body or agency,
against or affecting the Company or any of its subsidiaries relating to Hazardous Materials or any Environmental Laws.

 

(q) The
Company is not, and will not be, either after receipt of payment for the Securities or after the application of the proceeds therefrom
as described under “Use of Proceeds” in the Preliminary Memorandum, the Time of Sale Memorandum and the Final Memorandum,
required to register as an “investment company” under the Investment Company Act of 1940, as amended (the “Investment
Company Act”).

 

    	8

    	 

    

 

(r) Neither
the Company nor any affiliate (as defined in Rule 501(b) of Regulation D under the Securities Act, an “Affiliate”)
of the Company has directly, or through any agent, sold, offered for sale, solicited offers to buy or otherwise negotiated in
respect of, any security (as defined in the Securities Act) which is or will be integrated with the sale of the Securities in
a manner that would require the registration under the Securities Act of the Securities, made any General Solicitation that is
not an Additional Written Offering Communication other than General Solicitations listed on Schedule II hereto or those made with
the prior written consent of the Representative, or offered, solicited offers to buy or sold the Securities in any manner involving
a public offering within the meaning of Section 4(a)(2) of the Securities Act.

 

(s) Assuming
compliance by the Initial Purchasers with respect to their representations in Section 7 of this Agreement, it is not necessary
in connection with the offer, sale and delivery of the Securities to the Initial Purchasers in the manner contemplated by this
Agreement to register the Securities under the Securities Act or to qualify the Indenture under the Trust Indenture Act of 1939,
as amended.

 

(t) The
Securities satisfy the requirements set forth in Rule 144A(d)(3) under the Securities Act.

 

(u) (i)
None of the Company or its subsidiaries or controlled affiliates, or any director, officer, or employee thereof, or to the knowledge
of the Company, any agent or representative of the Company or of any of its subsidiaries or controlled affiliates, has taken or
will take any action in furtherance of an offer, payment, promise to pay, or authorization or approval of the payment, giving
or receipt of money, property, gifts or anything else of value, directly or indirectly, to any government official (including
any officer or employee of a government or government-owned or controlled entity or of a public international organization, or
any person acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official or
candidate for political office) in order to improperly influence official action, or to any person in each case in violation of
any applicable anti-corruption laws; (ii) the Company and its subsidiaries and controlled affiliates have conducted their businesses
in compliance with applicable anti-corruption laws and have instituted and maintained and will continue to maintain policies and
procedures reasonably designed to promote and achieve compliance with such laws and with the representations and warranties contained
herein; and (iii) neither the Company nor any of its subsidiaries will use, directly or indirectly, the proceeds of the offering
in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value,
to any person in violation of any applicable anti-corruption laws.

 

(v) The
operations of the Company and its subsidiaries are, and have been conducted at all times, in compliance with applicable financial
recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money
laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar applicable
rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the “Money
Laundering Laws”) and no action, suit or proceeding by or before any court or governmental agency, authority or body
or any arbitrator involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is pending or, to
the knowledge of the Company, threatened.

 

    	9

    	 

    

 

(w) Neither
the Company nor any of its subsidiaries, directors, officers, or employees, nor, to the knowledge of the Company, after due inquiry,
any agent, affiliate or other person acting on behalf of the Company or any of its subsidiaries is currently the subject or the
target of any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury (“OFAC”)
or the U.S. Department of State, the United Nations Security Council, the European Union, Her Majesty’s Treasury of the
United Kingdom, or other relevant sanctions authority (collectively, “Sanctions”); nor is the Company or any
of its subsidiaries located, organized or resident in a country or territory that is the subject or the target of Sanctions, including,
without limitation, Crimea, Cuba, Iran, North Korea, and Syria (each a “Sanctioned Country”); and the Company
will not directly or indirectly use the proceeds of this offering, or lend, contribute or otherwise make available such proceeds
to any subsidiary, or any joint venture partner or other person or entity, for the purpose of financing the activities of or business
with any person, or in any country or territory, that at the time of such financing, is the subject or the target of Sanctions
or in any other manner that will result in a violation by any person (including any person participating in the transaction whether
as underwriter, advisor, investor or otherwise) of applicable Sanctions. For the past five years, the Company and its subsidiaries
have not knowingly engaged in and are not now knowingly engaged in any dealings or transactions with any person that at the time
of the dealing or transaction is or was the subject or the target of Sanctions or with any Sanctioned Country.

 

(x) Except
pursuant to this Agreement, there is no broker, finder or other party that is entitled to receive from the Company any brokerage
or finder’s fee or other fee or commission as a result of any transactions contemplated by this Agreement.

 

(y) Each
financial or operational projection or other “forward-looking statement” (as defined by Section 27A of the Securities
Act or Section 21E of the Exchange Act) contained in the Preliminary Memorandum, the Time of Sale Memorandum or the Final Memorandum
(i) was so included by the Company in good faith and with reasonable basis after due consideration by the Company of the underlying
assumptions, estimates and other applicable facts and circumstances and (ii) is accompanied by meaningful cautionary statements
identifying those factors that could cause actual results to differ materially from those in such forward-looking statement. No
such statement was made with the knowledge of an executive officer or director of the Company that was false or misleading.

 

    	10

    	 

    

 

(z) Each
of L J Soldinger Associates, LLC, Marcum LLP, and Ernst & Young LLP, has expressed its opinion with respect to certain financial
statements (which term as used in this Agreement includes the related notes thereto) and supporting schedules included in each
of the Preliminary Memorandum, the Time of Sale Memorandum and the Final Memorandum. Each of KPMGUS LLP, L J Soldinger Associates,
LLC, Marcum LLP, and Ernst & Young LLP is (i) an independent registered public accounting firm as required by the Securities
Act, the Exchange Act, and the rules of the Public Company Accounting Oversight Board (“PCAOB”), (ii) in compliance
with the applicable requirements relating to the qualification of accountants under Rule 2-01 of Regulation S-X under the Securities
Act and (iii) a registered public accounting firm as defined by the PCAOB whose registration has not been suspended or revoked
and who has not requested such registration to be withdrawn.

 

(aa) The
financial statements together with the related schedules and notes, included in each of the Preliminary Memorandum, the Time of
Sale Memorandum and the Final Memorandum present fairly, in all material respects, the consolidated financial position of the
Company and each of its subsidiaries as of the dates indicated and the results of their operations, changes in stockholders’
equity and cash flows for the periods specified. Such financial statements have been prepared in conformity with generally accepted
accounting principles as applied in the United States applied on a consistent basis throughout the periods involved, except as
may be expressly stated in the related notes thereto. No other financial statements are required to be included in the Preliminary
Memorandum, the Time of Sale Memorandum and the Final Memorandum. The financial data set forth in each of the Preliminary Memorandum,
the Time of Sale Memorandum and the Final Memorandum under the captions “Summary Historical Financial Data of fuboTV Post-Merger”,
“Summary Historical Financial Data of fuboTV Pre-Merger”, “Summary Historical Financial Data of Facebank Pre-Merger”,
“Unaudited Pro Forma Combined Financial Information”, “Selected Historical Financial Data of FuboTV Post-Merger”,
“Selected Historical Financial Data of FuboTV Pre-Merger”, “Selected Historical Financial Data of Facebank Pre-Merger”,
“Reconciliation of Non-GAAP Measures and Metrics”, and “Capitalization” fairly present, in all material
respects, the information set forth therein on a basis consistent with that of the audited financial statements contained in the
Preliminary Memorandum, the Time of Sale Memorandum and the Final Memorandum. All disclosures contained in the Preliminary Memorandum,
the Time of Sale Memorandum, the Final Memorandum and any Additional Written Offering Communication, that constitute non-GAAP
financial measures (as defined by the rules and regulations under the Securities Act and the Exchange Act) comply with Regulation
G under the Exchange Act and Item 10 of Regulation S-K under the Securities Act, as applicable. To the Company’s knowledge,
no person who has been suspended or barred from being associated with a registered public accounting firm, or who has failed to
comply with any sanction pursuant to Rule 5300 promulgated by the PCAOB, has participated in or otherwise aided the preparation
of, or audited, the financial statements or other financial data included in the Preliminary Memorandum, the Time of Sale Memorandum,
the Final Memorandum or any Additional Written Offering Communication.

 

    	11

    	 

    

 

(bb) The
Company and its subsidiaries have good and marketable title to all of the real and personal property and other assets reflected
as owned in the Preliminary Memorandum, the Time of Sale Memorandum and the Final Memorandum, in each case free and clear of any
security interests, mortgages, liens, encumbrances, equities, adverse claims and other defects. The real property, improvements,
equipment and personal property held under lease by the Company or any of its subsidiaries are held under valid and enforceable
leases, with such exceptions as are not material and do not materially interfere with the use made or proposed to be made of such
real property, improvements, equipment or personal property by the Company or such subsidiary.

 

(cc) The
Company and its subsidiaries own, or have obtained valid and enforceable licenses for the inventions, technology, patent applications,
patents, trademarks, trade names, service names, copyrights, trade secrets, and other intellectual property described in the Preliminary
Memorandum, the Time of Sale Memorandum and the Final Memorandum as being owned or licensed by them or which are necessary for
the conduct of their respective businesses as currently conducted or as currently proposed to be conducted (collectively, “Intellectual
Property”), and the conduct of their respective businesses does not and will not infringe, misappropriate or otherwise
conflict in any material respect with any such rights of others. The Intellectual Property of the Company has not been adjudged
by a court of competent jurisdiction to be invalid or unenforceable, in whole or in part, and the Company is unaware of any facts
which would form a reasonable basis for any such adjudication. To the Company’s knowledge, there are no third parties who
have rights to any Intellectual Property, including no liens, security interests, or other encumbrances, except as otherwise disclosed
in the Preliminary Memorandum, the Time of Sale Memorandum and the Final Memorandum, and, to the Company’s knowledge, there
is no infringement by third parties of any Intellectual Property. Except as otherwise disclosed in the Preliminary Memorandum,
the Time of Sale Memorandum and the Final Memorandum, there is no pending or, to the Company’s knowledge, threatened, action,
suit, proceeding or claim by others: (A) challenging the Company’s rights in or to any Intellectual Property, and the Company
is unaware of any facts which would form a reasonable basis for any such action, suit, proceeding or claim; (B) challenging the
validity, enforceability or scope of any Intellectual Property and the Company is unaware of any facts which would form a reasonable
basis for any such action, suit, proceeding or claim; or (C) asserting that the Company or any of its subsidiaries infringes or
otherwise violates, or would, upon the commercialization of any product or service described in the the Preliminary Memorandum,
the Time of Sale Memorandum and the Final Memorandum as under development, infringe or violate, any patent, trademark, trade name,
service name, copyright, trade secret or other proprietary rights of others, and each of the Company and its subsidiaries is unaware
of any facts which would form a reasonable basis for any such action, suit, proceeding or claim. The Company and its subsidiaries
have complied in all material respects with the terms of each agreement pursuant to which Intellectual Property has been licensed
to the Company or any of its subsidiaries, and all such agreements are in full force and effect. To the Company’s knowledge,
there are no material defects in any of the patents or patent applications included in the Intellectual Property. The Company
and its subsidiaries have taken all reasonable steps to protect, maintain and safeguard their Intellectual Property, including
the execution of appropriate nondisclosure, confidentiality agreements and invention assignment agreements and invention assignments
with their employees and independent contractors, and to the Company’s knowledge, no employee or independent contractor
of the Company is in or has been in violation of any term of any employment or independent contractor agreement, patent disclosure
agreement, invention assignment agreement, non-competition agreement, non-solicitation agreement, nondisclosure agreement, or
any restrictive covenant to or with a former employer or counterparty where the basis of such violation relates to such employee’s
employment, or such independent contractor’s engagement, with the Company. The duty of candor and good faith as required
by the United States Patent and Trademark Office during the prosecution of the United States patents and patent applications included
in the Intellectual Property have been complied with; and in all foreign offices having similar requirements, all such requirements
have been complied with. None of the Intellectual Property or technology (including information technology and outsourced arrangements)
employed by the Company or its subsidiaries has been obtained or is being used by the Company or its subsidiaries in violation
of any contractual obligation binding on the Company or its subsidiaries or any of their respective officers, directors or employees
or otherwise in violation of the rights of any persons, including with respect to software or other materials distributed under
an “open source” or similar licensing model that meets the definition of “open source” promulgated by
the Open Source Initiative located online at http://opensource.org/osd (e.g., GNU General Public License, GNU Lesser General Public
License, and GNU Affero General Public License).

 

    	12

    	 

    

 

(dd) Neither
the Company, nor any of its subsidiaries, is in material default or material breach under the terms of any agreement necessary
for the conduct of their respective businesses as currently conducted or as currently proposed to be conducted (“Necessary
Agreements”), nor, to the Company’s knowledge, does any condition exist that, with notice or lapse of time or
both, would constitute a material default or material breach thereunder by the Company except, in each case, as otherwise disclosed
in the Preliminary Memorandum, the Time of Sale Memorandum and the Final Memorandum. The Company has not received any notice of
termination or cancellation under any Necessary Agreement, received any notice of breach or default in any material respect under
any Necessary Agreement or granted to any third party any rights, adverse or otherwise, that would constitute a breach of any
Necessary Agreement except, in each case, as otherwise disclosed in the Preliminary Memorandum, the Time of Sale Memorandum and
the Final Memorandum.

 

(ee) The
Company and its subsidiaries and any “employee benefit plan” (as defined under the Employee Retirement Income Security
Act of 1974, as amended, and the regulations and published interpretations thereunder (collectively, “ERISA”))
established or maintained by the Company, its subsidiaries, or their “ERISA Affiliates” (as defined below) are in
compliance in all material respects with ERISA. “ERISA Affiliate” means, with respect to the Company or any
of its subsidiaries, any member of any group of organizations described in Sections 414(b), (c), (m) or (o) of the Internal Revenue
Code of 1986, as amended, and the regulations and published interpretations thereunder (the “Code”) of which
the Company or any of its subsidiaries is a member. No “reportable event” (as defined under ERISA) has occurred or
is reasonably expected to occur with respect to any “employee benefit plan” established or maintained by the Company,
its subsidiaries or any of their ERISA Affiliates, that could reasonably be expected to result in a Material Adverse Change. No
“employee benefit plan” established or maintained by the Company, its subsidiaries or any of their ERISA Affiliates,
if such “employee benefit plan” were terminated, would have any “amount of unfunded benefit liabilities”
(as defined under ERISA), that could reasonably be expected to result in a Material Adverse Change. Neither the Company, its subsidiaries
nor any of their ERISA Affiliates has incurred or reasonably expects to incur any material liability under (i) Title IV of ERISA
with respect to termination of, or withdrawal from, any “employee benefit plan” or (ii) Sections 412, 4971, 4975 or
4980B of the Code. Each employee benefit plan established or maintained by the Company, its subsidiaries or any of their ERISA
Affiliates that is intended to be qualified under Section 401(a) of the Code is so qualified and nothing has occurred, whether
by action or failure to act, which would reasonably be expected to cause the loss of such qualification.

 

(ff) Each
of the Company and its subsidiaries are insured by recognized, financially sound and reputable institutions with policies in such
amounts and with such deductibles and covering such risks as the Company reasonably believes is adequate and customary for their
businesses including, but not limited to, policies covering real and personal property owned or leased by the Company and its
subsidiaries against theft, damage, destruction, acts of vandalism and policies covering the Company and its subsidiaries for
product liability claims. The Company has no reason to believe that it or any of its subsidiaries will not be able (i) to renew
its existing insurance coverage as and when such policies expire or (ii) to obtain comparable coverage from similar institutions
as may be necessary or appropriate to conduct its business as now conducted and at a cost that could not reasonably be expected
to result in a Material Adverse Change. Neither the Company nor any of its subsidiaries has been denied any insurance coverage
which it has sought or for which it has applied.

 

    	13

    	 

    

 

(gg) The
Company and its subsidiaries possess such valid and current licenses, certificates, authorizations, approvals, consents or permits
required by state, federal or foreign regulatory agencies or bodies, including, without limitation, any permits required by the
Federal Communications Commission, to conduct their respective businesses as currently conducted and as described in the Preliminary
Memorandum, the Time of Sale Memorandum and the Final Memorandum (“Permits”). Neither the Company, nor any
of its subsidiaries is in violation of, or in default under, any of the Permits or has received any notice of proceedings relating
to the revocation or suspension of, or non-compliance with, any such certificate, authorization or permit. The Company and its
subsidiaries have filed, obtained, maintained or submitted all reports, documents, forms, notices, applications, records, claims,
submissions and supplements or amendments as required by any Permits and that all such reports, documents, forms, notices, applications,
records, claims, submissions and supplements or amendments were timely, complete, correct and not misleading on the date filed
(or were corrected or supplemented by a subsequent submission), except, in each case, where the failure to do so would not reasonably
be expected, individually or in the aggregate, to result in a Material Adverse Change.

 

(hh) The
Company and its subsidiaries have timely filed all necessary federal, state and foreign income, franchise and other material tax
returns or have properly requested extensions thereof, and have paid all taxes required to be paid by any of them (whether or
not reflected on any tax return) and, if due and payable, any related or similar assessment, fine or penalty levied against any
of them except as may be being contested in good faith and by appropriate proceedings, to the extent that failure to file or pay
could reasonably be expected to result in a Material Adverse Change. The Company has made adequate charges, accruals and reserves
in the Company’s applicable financial statements in respect of all federal, state and foreign income, franchise and other
material taxes for all periods as to which the tax liability of the Company or any of its subsidiaries has not been finally determined,
to the extent that the failure to do so could reasonably be expected to result in a Material Adverse Change. No tax deficiency
has been determined adversely to the Company or its subsidiaries nor does the Company or its subsidiaries have any written notice
or knowledge of any tax deficiency which would reasonably be expected to be determined adversely to the Company or its subsidiaries
and could reasonably be expected to result in a Material Adverse Change. There are no outstanding agreements or waivers extending
the statutory period of limitation applicable to any federal, state, local or foreign tax return for any period.

 

(ii) Except
as otherwise disclosed in the Preliminary Memorandum, the Time of Sale Memorandum and the Final Memorandum, the Company and each
of its subsidiaries make and keep accurate books and records and maintain a system of internal accounting controls sufficient
to provide reasonable assurance that: (i) transactions are executed in accordance with management’s general or specific
authorization; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with generally
accepted accounting principles as applied in the United States and to maintain accountability for assets; (iii) access to assets
is permitted only in accordance with management’s general or specific authorization; (iv) the recorded accountability for
assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences;
and (v) the interactive data in eXtensible Business Reporting Language included in or incorporated by reference in the Preliminary
Memorandum, the Time of Sale Memorandum or the Final Memorandum fairly presents the information called for in all material respects
and is prepared in accordance with the Commission’s rules and guidelines applicable thereto.

 

    	14

    	 

    

 

(jj) All
statistical, demographic and market-related data included in the Preliminary Memorandum, the Time of Sale Memorandum and the Final
Memorandum are based on or derived from sources that the Company believes, after reasonable inquiry, to be reliable and accurate.
To the extent required, the Company has obtained the written consent to the use of such data from such sources.

 

(kk) Except
as otherwise disclosed in the Preliminary Memorandum, the Time of Sale Memorandum and the Final Memorandum, the Company has established
and maintains disclosure controls and procedures (as defined in Rules 13a-15 and 15d-15 under the Exchange Act), which (i) are
designed to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to
the Company’s principal executive officer and its principal financial officer by others within those entities, particularly
during the periods in which the periodic reports required under the Exchange Act are being prepared; (ii) have been evaluated
by management of the Company for effectiveness as of the end of the Company’s most recent fiscal quarter; and (iii) are
effective in all material respects to perform the functions for which they were established. Except as otherwise disclosed in
the Preliminary Memorandum, the Time of Sale Memorandum and the Final Memorandum, since the end of the Company’s most recent
audited fiscal year, there have been no significant deficiencies or material weakness in the Company’s internal control
over financial reporting (whether or not remediated) and no change in the Company’s internal control over financial reporting
that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial
reporting. The Company is not aware of any change in its internal control over financial reporting that has occurred during its
most recent fiscal quarter that has materially adversely affected, or is reasonably likely to materially adversely affect, the
Company’s internal control over financial reporting.

 

(ll) Except
as described in the Preliminary Memorandum, the Time of Sale Memorandum and the Final Memorandum, the Company has not sold, issued
or distributed any shares of Common Stock during the six-month period preceding the date hereof, including any sales pursuant
to Rule 144A under, or Regulation D or S of, the Securities Act, other than shares issued pursuant to employee benefit plans,
qualified stock option plans or other employee compensation plans or pursuant to outstanding options, rights or warrants.

 

(mm) There
is, and has been, no failure on the part of the Company or any of the Company’s directors or officers, in their capacities
as such, to comply with any applicable provision of the Sarbanes-Oxley Act of 2002, as amended, and the rules and regulations
promulgated in connection therewith, including Section 402 related to loans and Sections 302 and 906 related to certifications.

 

    	15

    	 

    

 

(nn) Neither
the Company, nor any of its subsidiaries has taken, directly or indirectly, any action designed to or that would be expected to
cause or result in stabilization or manipulation of the price of the capital stock of the Company or of any “reference security”
(as defined in Rule 100 of Regulation M under the Exchange Act (“Regulation M”)) with respect to the capital
stock of the Company, whether to facilitate the sale or resale of the Securities or otherwise, and has taken no action which would
directly or indirectly violate Regulation M.

 

(oo) There
are no business relationships or related-party transactions involving the Company or any of its subsidiaries or any other person
required to be described in the Preliminary Memorandum, the Time of Sale Memorandum or the Final Memorandum that have not been
described as required.

 

(pp) The
Company does not have any outstanding extension of credit, in the form of a personal loan, to or for any director or executive
officer (or equivalent thereof) of the Company except for such extensions of credit as are expressly permitted by Section 13(k)
of the Exchange Act.

 

(qq) All
of the information provided to the Initial Purchasers or to counsel for the Initial Purchasers by the Company, its counsel, its
officers and directors and, to the Company’s knowledge, the holders of any securities (debt or equity) or options to acquire
any securities of the Company in connection with the offering of the Securities is true, complete and correct in all material
respects and compliant with FINRA’s rules and any letters, filings or other supplemental information provided to FINRA pursuant
to FINRA Rules or NASD Conduct Rules is true, complete and correct in all material respects.

 

(rr) The
Company has furnished to the Initial Purchasers a letter agreement in the form attached hereto as Exhibit A (the “Lock-up
Agreement”) from the directors and officers of the Company and from certain securityholders of the Company. If any additional
persons shall become directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) of the Company prior to the end
of the Restricted Period (as defined below), the Company shall use best efforts to cause each such person, prior to or contemporaneously
with their appointment or election as a director or officer of the Company, to execute and deliver to the Representative a Lock-up
Agreement.

 

    	16

    	 

    

 

(ss) The
Company and its subsidiaries’ information technology assets and equipment, computers, systems, networks, hardware, software,
websites, applications, and databases (collectively, “IT Systems”) are adequate for, and operate and perform
in all material respects as required in connection with the operation of the business of the Company and its subsidiaries as currently
conducted, free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants. The
Company and its subsidiaries have implemented and maintained commercially reasonable physical, technical and administrative controls,
policies, procedures, and safeguards to maintain and protect their material confidential information and the integrity, continuous
operation, redundancy and security of all IT Systems and data, including all Personal Data (defined below) and all sensitive,
confidential or regulated data (“Confidential Data”) used in connection with their businesses. “Personal
Data” means (i) a natural person’s name, street address, telephone number, e-mail address, photograph, social
security number or tax identification number, driver’s license number, passport number, credit card number, bank information,
or customer or account number; (ii) any information which would qualify as “personally identifying information” under
the Federal Trade Commission Act, as amended; (iii) “personal data” as defined by GDPR (as defined below); (iv) any
information which would qualify as “protected health information” under the Health Insurance Portability and Accountability
Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act (collectively, “HIPAA”);
(v) any “personal information” as defined by the California Consumer Privacy Act (“CCPA”); and
(vi) any other piece of information that allows the identification of such natural person, or his or her family, or permits the
collection or analysis of any data related to an identified person’s health or sexual orientation. There have been no breaches,
violations, outages or unauthorized uses of or accesses to same, except for those that have been remedied without material cost
or liability or the duty to notify any other person, nor any incidents under internal review or investigations relating to the
same. The Company and its subsidiaries are presently in material compliance with all applicable laws or statutes and all judgments,
orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual
obligations relating to the privacy and security of IT Systems, Confidential Data, and Personal Data and to the protection of
such IT Systems, Confidential Data, and Personal Data from unauthorized use, access, misappropriation or modification.

 

(tt) The
Company and its subsidiaries are, and at all prior times were, in material compliance with all applicable state and federal data
privacy and security laws and regulations, including without limitation HIPAA, CCPA, and the European Union General Data Protection
Regulation (“GDPR”) (EU 2016/679) (collectively, the “Privacy Laws”). To ensure compliance
with the Privacy Laws, the Company and its subsidiaries have in place, comply with, and take appropriate steps to ensure compliance
in all material respects with their policies and procedures relating to data privacy and security and the collection, storage,
use, processing, disclosure, handling, and analysis of Personal Data and Confidential Data (the “Policies”).
The Company and its subsidiaries have at all times made all disclosures to users or customers required by applicable laws and
regulatory rules or requirements, and none of such disclosures made or contained in any Policy have been inaccurate or in violation
of any applicable laws and regulatory rules or requirements in any material respect. The Company further certifies that neither
it nor any subsidiary: (i) has received notice of any actual or potential liability under or relating to, or actual or potential
violation of, any of the Privacy Laws, and has no knowledge of any event or condition that would reasonably be expected to result
in any such notice; (ii) is currently conducting or paying for, in whole or in part, any investigation, remediation, or other
corrective action pursuant to any Privacy Law; or (iii) is a party to any order, decree, or agreement that imposes any obligation
or liability under any Privacy Law.

 

    	17

    	 

    

 

(uu) The
issuance and sale of the Securities to be sold by the Company as contemplated hereby will not cause any holder of any shares of
capital stock, securities convertible into or exchangeable or exercisable for capital stock or options, warrants or other rights
to purchase capital stock or any other securities of the Company to have any right to acquire any shares of preferred stock of
the Company.

 

(vv) Neither
the Company nor any of its subsidiaries has sent or received any communication regarding termination of, or intent not to renew,
any of the contracts or agreements referred to or described in the Preliminary Memorandum, the Time of Sale Memorandum and the
Final Memorandum, and no such termination or non-renewal has been threatened by the Company or any of its subsidiaries or, to
the Company’s knowledge, any other party to any such contract or agreement, which threat of termination or non-renewal has
not been rescinded as of the date hereof.

 

(ww) Except
as otherwise disclosed in the Preliminary Memorandum, the Time of Sale Memorandum and the Final Memorandum, no subsidiary of the
Company is prohibited or restricted, directly or indirectly, from paying dividends to the Company, or from making any other distribution
with respect to such subsidiary’s equity securities or from repaying to the Company or any other subsidiary of the Company
any amounts that may from time to time become due under any loans or advances to such subsidiary from the Company or from transferring
any property or assets to the Company or to any other subsidiary.

 

2. Agreements
to Sell and Purchase. The Company hereby agrees to sell to the several Initial Purchasers, and each Initial Purchaser, upon
the basis of the representations and warranties herein contained, but subject to the terms and conditions hereinafter stated,
agrees, severally and not jointly, to purchase from the Company the respective principal amount of Firm Securities set forth in
Schedule I hereto opposite its name at a purchase price of 97.25% of the principal amount thereof (the “Purchase Price”)
plus accrued interest, if any, to the Closing Date (as defined in Section 4).

 

On
the basis of the representations and warranties contained in this Agreement, and subject to its terms and conditions, the Company
agrees to sell to the Initial Purchasers the Additional Securities, and the Initial Purchasers shall have the right to purchase,
severally and not jointly, up to $52,500,000 principal amount of Additional Securities at the Purchase Price plus accrued interest,
if any, to the date of payment and delivery. The Representative may exercise this right on behalf of the Initial Purchasers in
whole or from time to time in part by giving written notice to the Company, provided that any Option Closing Date (as defined
below) shall occur within a period (the “Exercise Period”) of thirteen calendar days from, and including, the
Closing Date. Any exercise notice shall specify the principal amount of Additional Securities to be purchased by the Initial Purchasers
and the date on which such Additional Securities are to be purchased. Each purchase date must be within the Exercise Period, and
must be at least one business day after the written notice is given and may not be earlier than the Closing Date nor later than
ten business days after the date of such notice. On each day, if any, that Additional Securities are to be purchased (an “Option
Closing Date”), each Initial Purchaser agrees, severally and not jointly, to purchase the principal amount of Additional
Securities (subject to such adjustments to eliminate fractional Securities as the Representative may determine) that bears the
same proportion to the total principal amount of Additional Securities to be purchased on such Option Closing Date as the principal
amount of Firm Securities set forth in Schedule I opposite the name of such Initial Purchaser bears to the total principal amount
of Firm Securities.

 

    	18

    	 

    

 

3. Terms
of Offering. The Representative has advised the Company that the Initial Purchasers will make an offering of the
Securities purchased by the Initial Purchasers hereunder as soon as practicable after this Agreement is entered into as in
the Representative’s judgment is advisable.

 

4. Payment
and Delivery. Payment for the Firm Securities shall be made to the Company in Federal or other funds immediately available
in New York City against delivery of such Firm Securities for the respective accounts of the several Initial Purchasers at 10:00
a.m., New York City time, on February 2, 2021, or at such other time on the same or such other date, not later than February 9,
2021, as shall be designated in writing by the Representative. The time and date of such payment are hereinafter referred to as
the “Closing Date.”

 

Payment
for any Additional Securities shall be made to the Company in Federal or other funds immediately available in New York City against
delivery of such Additional Securities for the respective accounts of the several Initial Purchasers at 10:00 a.m., New York City
time, on the date specified in the corresponding notice described in Section 2 or at such other time on the same or on such other
date, in any event not later than the last day of the Exercise Period, as shall be designated in writing by the Representative.

 

The
Securities shall be in definitive form or global form, as specified by the Representative, and registered in such names and in
such denominations as the Representative shall request in writing not later than one full business day prior to the Closing Date
or the applicable Option Closing Date, as the case may be. The Securities shall be delivered to the Representative on the Closing
Date or an Option Closing Date, as the case may be, for the respective accounts of the several Initial Purchasers, with any transfer
taxes payable in connection with the transfer of the Securities duly paid by the Company.

 

    	19

    	 

    

 

5. Conditions
to the Initial Purchasers’ Obligations. The several obligations of the Initial Purchasers to purchase and pay for
the Firm Securities on the Closing Date are subject to the following conditions:

 

(a)
Subsequent to the execution and delivery of this Agreement and prior to the Closing Date:

 

(i)
there shall not have occurred any downgrading, nor shall any notice have been given of any intended or potential downgrading or
of any review for a possible change that does not indicate the direction of the possible change, in the rating accorded any of
the securities of the Company or any of its subsidiaries by any “nationally recognized statistical rating organization,”
as such term is defined in Section 3(a)(62) of the Exchange Act; and

 

(ii)
there shall not have occurred any change, or any development involving a prospective change, in the condition, financial or otherwise,
or in the earnings, business or operations of the Company and its subsidiaries, taken as a whole, from that set forth in the Time
of Sale Memorandum provided to the prospective purchasers of the Securities that, in the judgment of the Representative, is material
and adverse and that makes it, in the judgment of the Representative, impracticable to market the Securities on the terms and
in the manner contemplated in the Time of Sale Memorandum.

 

(b)
The Initial Purchasers shall have received on the Closing Date a certificate, dated the Closing Date and signed on behalf of the
Company by an executive officer of the Company, to the effect set forth in Sections 5(a)(i) and 5(a)(ii) above and to the effect
that the representations and warranties of the Company contained in this Agreement are true and correct as of the Closing Date
and that the Company has complied with all of the agreements and satisfied all of the conditions on its part to be performed or
satisfied hereunder on or before the Closing Date.

 

The
officer signing and delivering such certificate may rely upon his or her knowledge as to proceedings threatened.

 

(c)
The Initial Purchasers shall have received on the Closing Date an opinion and negative assurance letter of Wilson Sonsini Goodrich
& Rosati, Professional Corporation, outside counsel for the Company, dated the Closing Date, in form and substance reasonably
satisfactory to the Representative.

 

(d)
The Initial Purchasers shall have received on the Closing Date an opinion of Anthony L.G., PLLC, outside Florida counsel for the
Company, dated the Closing Date, in form and substance reasonably satisfactory to the Representative.

 

(e)
The Initial Purchasers shall have received on the Closing Date an opinion and negative assurance letter of Cooley LLP, counsel
for the Initial Purchasers, dated the Closing Date, in form and substance satisfactory to the Representative.

 

    	20

    	 

    

 

With
respect to Sections (c) and (e) above, each of Wilson Sonsini Goodrich & Rosati, Professional Corporation and Cooley LLP may
state that their opinions and beliefs are based upon their participation in the preparation of the Time of Sale Memorandum and
the Final Memorandum and any amendments or supplements thereto and review and discussion of the contents thereof, but are without
independent check or verification, except as specified.

 

The
opinions and negative assurance letters, as applicable, of Wilson Sonsini Goodrich & Rosati, Professional Corporation and
Anthony L.G., PLLC described in Sections 5(c) and 5(d) above shall be rendered to the Initial Purchasers at the request of the
Company and shall so state therein.

 

(f)
The Initial Purchasers shall have received on each of the date hereof and the Closing Date a letter, dated the date hereof or
the Closing Date, as the case may be, in form and substance satisfactory to the Initial Purchasers, from each of KPMG US LLP,
L J Soldinger Associates, LLC, Marcum LLP, and Ernst & Young LLP, each an independent registered public accounting firm, containing
statements and information of the type ordinarily included in accountants’ “comfort letters” to underwriters
with respect to the financial statements and certain financial information contained in or incorporated by reference into the
Preliminary memorandum, the Time of Sale Memorandum and the Final Memorandum; provided that the letter delivered on the
Closing Date shall use a “cut-off date” not earlier than the date hereof.

 

(g)
The Lock-up Agreements, each substantially in the form of Exhibit A hereto, executed by certain securityholders and by
all executive officers and directors of the Company, relating to restrictions on sales and certain other dispositions of shares
of Common Stock or certain other securities, delivered to the Representative on or before the date hereof, shall be in full force
and effect on the Closing Date.

 

(h)
The chief financial officer of the Company shall have delivered to the Initial Purchasers, on each of the date hereof and on the
Closing Date, a certificate in a form reasonably acceptable to the Representative.

 

(i)
The Securities shall be eligible for clearance and settlement through The Depository Trust Company.

 

(j)
An application for the listing of the Underlying Securities shall have been submitted to the New York Stock Exchange (the “Exchange”).

 

(k)
The several obligations of the Initial Purchasers to purchase Additional Securities hereunder are subject to the delivery to the
Representative on the applicable Option Closing Date of the following:

 

(i)
a certificate, dated the Option Closing Date and signed by an executive officer of the Company, confirming that the certificate
delivered on the Closing Date pursuant to Section 5(b) hereof remains true and correct as of such Option Closing Date;

 

    	21

    	 

    

 

(ii)
an opinion and negative assurance letter of Wilson Sonsini Goodrich & Rosati, Professional Corporation, outside counsel for
the Company, dated the Option Closing Date, relating to the Additional Securities to be purchased on such Option Closing Date
and otherwise to the same effect as the opinion and negative assurance letter required by Section 5(c) hereof;

 

(iii)
an opinion of Anthony L.G., PLLC, outside Florida counsel for the Company, dated the Option Closing Date, relating to the Additional
Securities to be purchased on such Option Closing Date and otherwise to the same effect as the opinion required by Section 5(d)
hereof;

 

(iv)
an opinion and negative assurance letter of Cooley LLP, counsel for the Initial Purchasers, dated the Option Closing Date, relating
to the Additional Securities to be purchased on such Option Closing Date and otherwise to the same effect as the opinion and negative
assurance letter required by Section 5(e) hereof;

 

(v)
a letter dated the Option Closing Date, in form and substance satisfactory to the Initial Purchasers, from each of KPMG US LLP,
L J Soldinger Associates, LLC, Marcum LLP, and Ernst & Young LLP, each an independent registered public accounting firm, substantially
in the same form and substance as the letter furnished to the Initial Purchasers pursuant to Section 5(f) hereof; provided
that the letter delivered on the Option Closing Date shall use a “cut-off date” not earlier than three business
days prior to such Option Closing Date;

 

(vi)
a certificate, dated the Option Closing Date and signed by the chief financial officer of the Company substantially in the same
form and substance as the certificate furnished to the Initial Purchasers pursuant to Section 5(h) hereof; and

 

(vii)
such other certificates and documents as the Representative may reasonably request, including without limitation with respect
to the good standing of the Company and its subsidiaries, the due authorization and issuance of the Additional Securities to be
sold on such Option Closing Date, and other matters related to the sale of such Additional Securities.

 

6.
Covenants of the Company. The Company covenants with each Initial Purchaser as follows:

 

(a)
To furnish to the Representative, without charge, prior to 10:00 a.m. New York City time on the business day next succeeding the
date of this Agreement and during the period mentioned in Section 6(d) or (e), as many copies of the Time of Sale Memorandum,
the Final Memorandum, any documents incorporated by reference therein and any supplements and amendments thereto as the Representative
may reasonably request.

 

    	22

    	 

    

 

(b)
Before amending or supplementing the Preliminary Memorandum, the Time of Sale Memorandum or the Final Memorandum, to furnish to
the Representative a copy of each such proposed amendment or supplement and not to use or refer to any such proposed amendment
or supplement to which the Representative reasonably objects.

 

(c)
To furnish to the Representative a copy of each proposed Additional Written Offering Communication to be prepared by or on behalf
of, used by, or referred to by the Company and not to use or refer to any proposed Additional Written Offering Communication to
which the Representative reasonably objects.

 

(d)
If the Time of Sale Memorandum is being used to solicit offers to buy the Securities at a time when the Final Memorandum is not
yet available to prospective purchasers and any event shall occur or condition exist as a result of which it is necessary to amend
or supplement the Time of Sale Memorandum in order to make the statements therein, in the light of the circumstances, not misleading,
or if, in the opinion of counsel for the Initial Purchasers, it is necessary to amend or supplement the Time of Sale Memorandum
to comply with applicable law, forthwith to prepare and furnish, at its own expense, to the Initial Purchasers and to any dealer
upon request, either amendments or supplements to the Time of Sale Memorandum so that the statements in the Time of Sale Memorandum
as so amended or supplemented will not, in the light of the circumstances when the Time of Sale Memorandum is delivered to a prospective
purchaser, be misleading or so that the Time of Sale Memorandum, as amended or supplemented, will comply with applicable law.

 

(e)
If, during such period after the date hereof and prior to the date on which all of the Securities shall have been sold by the
Initial Purchasers, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Final
Memorandum in order to make the statements therein, in the light of the circumstances when the Final Memorandum is delivered to
a purchaser, not misleading, or if, in the opinion of counsel for the Initial Purchasers, it is necessary to amend or supplement
the Final Memorandum to comply with applicable law, forthwith to prepare and furnish, at its own expense, to the Initial Purchasers
and to the dealers (whose names and addresses the Representative will furnish to the Company) to which Securities may have been
sold by the Representative on behalf of the Initial Purchasers and to any other dealers upon request, either amendments or supplements
to the Final Memorandum so that the statements in the Final Memorandum as so amended or supplemented will not, in the light of
the circumstances when the Final Memorandum is delivered to a purchaser, be misleading or so that the Final Memorandum, as amended
or supplemented, will comply with applicable law.

 

    	23

    	 

    

 

(f)
To endeavor to qualify the Securities for offer and sale under the securities or Blue Sky laws of such jurisdictions as the Representative
shall reasonably request; provided that in no event shall the Company be obligated to qualify to do business in any jurisdiction
where it is not now so qualified or to take any action that would subject it to service of process in suits, other than those
arising out of the offering or sale of the Securities, or taxation in any jurisdiction where it is not now so subject.

 

(g)
To make generally available to the Company’s security holders and to the Representative as soon as practicable an earnings
statement covering a period of at least twelve months beginning with the first fiscal quarter of the Company occurring after the
date of this Agreement which shall satisfy the provisions of Section 11(a) of the Securities Act and the rules and regulations
of the Commission thereunder.

 

(h)
Whether or not the transactions contemplated in this Agreement are consummated or this Agreement is terminated, the Company shall
pay or cause to be paid all expenses incident to the performance of its obligations under this Agreement, including: (i) the fees,
disbursements and expenses of the Company’s counsel and the Company’s accountants in connection with the issuance
and sale of the Securities and all other fees or expenses in connection with the preparation of the Preliminary Memorandum, the
Time of Sale Memorandum, the Final Memorandum, any Additional Written Offering Communication prepared by or on behalf of, used
by, or referred to by the Company and amendments and supplements to any of the foregoing, including all printing costs associated
therewith, and the mailing and delivering of copies thereof to the Initial Purchasers and dealers, in the quantities herein above
specified; (ii) all costs and expenses related to the transfer and delivery of the Securities to the Initial Purchasers, including
any transfer or other taxes payable thereon; (iii) the reasonable cost of printing or producing any Blue Sky or legal investment
memorandum in connection with the offer and sale of the Securities under state securities laws and all expenses in connection
with the qualification of the Securities for offer and sale under state securities laws as provided in Section 6(f) hereof, including
filing fees and the reasonable and documented fees and disbursements of counsel for the Initial Purchasers in connection with
such qualification and in connection with the Blue Sky or legal investment memorandum (provided that the amount payable by the
Company with respect the fees and disbursements of counsel for the Initial Purchasers incurred pursuant to this subsection (iii)
of Section 6(h) shall not exceed $10,000 in the aggregate); (iv) any fees charged by rating agencies for the rating of the Securities;
(v) the fees and expenses, if any, incurred in connection with the admission of the Securities for trading any appropriate market
system and all costs and expenses incident to listing the Underlying Securities on the Exchange; (vi) the costs and charges of
the Trustee and any transfer agent, registrar or depositary, (vii) the costs of the preparation, issuance and delivery of the
Securities, (viii) the costs and expenses of the Company relating to investor presentations on any “road show” undertaken
in connection with the marketing of the offering of the Securities, including, without limitation, expenses associated with the
preparation or dissemination of any electronic road show, expenses associated with the production of road show slides and graphics,
fees and expenses of any consultants engaged in connection with the road show presentations with the prior approval of the Company,
travel and lodging expenses of the representatives and officers of the Company and any such consultants, and fifty percent (50%)
of the cost of any aircraft chartered in connection with the road show for use by the Company and the Initial Purchasers (the
remaining fifty percent (50%) of the cost of such aircraft to be paid by the Initial Purchasers), (ix) the document production
charges and expenses associated with printing this Agreement, and (x) all other costs and expenses incident to the performance
of the obligations of the Company hereunder for which provision is not otherwise made in this Section. It is understood, however,
that except as provided in this Section, Section 8, and the last paragraph of Section 10, the Initial Purchasers will pay all
of their costs and expenses, including fees and disbursements of their counsel, stock transfer taxes payable on resale of any
of the Securities by them and any advertising expenses connected with any offers they may make and any travel and lodging costs
incurred by them in connection with any road show.

 

    	24

    	 

    

 

(i)
Neither the Company nor any Affiliate will sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of
any security (as defined in the Securities Act) which could be integrated with the sale of the Securities in a manner which would
require the registration under the Securities Act of the Securities.

 

(j)
To furnish the Representative with any proposed General Solicitation to be made by the Company or on its behalf before its use,
and not to make or use any proposed General Solicitation without the Representative’s prior written consent.

 

(k)
While any of the Securities or the Underlying Securities remain “restricted securities” within the meaning of the
Securities Act, to make available, upon request, to any seller of such Securities the information specified in Rule 144A(d)(4)
under the Securities Act, unless the Company is then subject to Section 13 or 15(d) of the Exchange Act.

 

(l)
During the period of one year after the Closing Date or any Option Closing Date, if later, the Company will not be, nor will it
become, an open-end investment company, unit investment trust or face-amount certificate company that is or is required to be
registered under Section 8 of the Investment Company Act.

 

(m)
During the period of one year after the Closing Date or any Option Closing Date, if later, the Company will not, and will not
permit any person that is an affiliate (as defined in Rule 144 under the Securities Act) at such time (or has been an affiliate
within the three months preceding such time) to, resell any of the Securities or the Underlying Securities which constitute “restricted
securities” under Rule 144 that have been reacquired by any of them.

 

(n)
Not to take any action prohibited by Regulation M under the Exchange Act in connection with the distribution of the Securities
contemplated hereby.

 

(o)
For as long as the Securities are outstanding, to cause to be listed, and maintain the listing of, the Underlying Securities on
the Exchange.

 

(p)
To reserve and keep available at all times, free of preemptive rights, shares of Common Stock in an amount equal to the Maximum
Number of Underlying Securities for the purpose of enabling the Company to satisfy all obligations to issue Underlying Securities
upon conversion of the Securities.

 

The
Company also covenants with each Initial Purchaser that, without the prior written consent of the Representative on behalf of
the Initial Purchasers, it will not, during the period ending 60 days after the date of the Final Memorandum (the “Restricted
Period”), and will not publicly disclose an intention to, (1) offer, pledge, sell, contract to sell, sell any option
or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise
transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or
exchangeable for Common Stock or (2) enter into any swap or other arrangement that transfers to another, in whole or in part,
any of the economic consequences of ownership of the Common Stock, whether any such transaction described in clause (1) or (2)
above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise or (3) confidentially submit
any draft registration statement or file any registration statement with the Commission relating to the offering of any shares
of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock.

 

The
restrictions contained in the preceding paragraph shall not apply to (a) the sale of the Securities under this Agreement, (b)
the issuance by the Company of shares of Common Stock upon the exercise of an option or warrant or the conversion of a security
outstanding on the date hereof of which the Initial Purchasers have been advised in writing, (c) the grant of options, restricted
stock units or any other type of equity award described in the Time of Sale Memorandum and the Final Memorandum pursuant to employee
benefit plans in effect on the date hereof and described in the Time of Sale Memorandum and the Final Memorandum, or the issuance
of shares of Common Stock by the Company (whether upon the exercise of stock options or other equity awards) to employees, officers,
directors, advisors or consultants of the Company pursuant to employee benefit plans in effect on the date hereof and described
in the Time of Sale Memorandum and the Final Memorandum; provided that each newly appointed director or executive officer
(including a newly appointed director or executive officer that is appointed during the Restricted Period) that is a recipient
of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock pursuant to this clause (c)
shall execute a Lock-up Agreement substantially in the form of Exhibit A hereto with respect to the remaining portion of
the Restricted Period, (d) the filing by the Company of a registration statement on Form
S-8 relating to the issuance, vesting, exercise or settlement of equity awards granted or to be granted pursuant to any employee
benefit plan in effect on the date hereof and described in the Time of Sale Memorandum, (e) the establishment of a trading
plan pursuant to Rule 10b5-1 under the Exchange Act for the transfer of shares of Common Stock, provided that (i) such
plan does not provide for the transfer of Common Stock during the Restricted Period and (ii) to the extent a public announcement
or filing under the Exchange Act, if any, is required of or voluntarily made by the Company regarding the establishment of such
plan, such announcement or filing shall include a statement to the effect that no transfer of Common Stock may be made under such
plan during the Restricted Period, or (f) the issuance of or entry into an agreement to issue Common Stock or any securities convertible
into or exercisable or exchangeable for Common Stock in connection with one or more mergers; acquisitions of securities, businesses,
property or other assets, products or technologies; joint ventures; commercial relationships or other strategic corporate transactions
or alliances; provided that the aggregate amounts of Common Stock or any securities convertible into or exercisable or
exchangeable for Common Stock (on an as-converted, as-exercised or as-exchanged basis) that the Company may issue or agree to
issue pursuant to this paragraph shall not exceed 5% of the total number of shares of Common Stock of the Company issued and outstanding
immediately following the completion of the transactions contemplated by this Agreement determined on a fully-diluted basis, and
provided further that each newly appointed director or executive officer (including a newly appointed director or executive
officer that is appointed during the Restricted Period) that is a recipient of Common Stock or any securities convertible into
or exercisable or exchangeable for Common Stock pursuant to this clause (f) shall execute a Lock-up Agreement substantially in
the form of Exhibit A hereto with respect to the remaining portion of the Restricted Period.

 

    	25

    	 

    

 

7.
Offering of Securities; Restrictions on Transfer.

 

(a)
Each Initial Purchaser, severally and not jointly, represents and warrants that such Initial Purchaser is a QIB. Each Initial
Purchaser, severally and not jointly, agrees with the Company that (i) it will not solicit offers for, or offer or sell, such
Securities by any General Solicitation, other than (x) a permitted communication listed on Schedule II hereto, or (y) those made
with the prior written consent of the Company, or in any manner involving a public offering within the meaning of Section 4(a)(2)
of the Securities Act, and (ii) it will sell such Securities in the United States only to persons that it reasonably believes
to be QIBs and that, in purchasing such Securities are deemed to have represented and agreed as provided in the Final Memorandum
under the captions “Notice to Investors” and “Transfer Restrictions”.

 

(b)
The Company agrees that the Initial Purchasers may provide copies of the Preliminary Memorandum, the Time of Sale Memorandum,
the Final Memorandum and any other agreements or documents relating thereto, including without limitation, the Indenture, to Xtract
Research LLC (“Xtract”), following completion of the offering, for inclusion in an online research service sponsored
by Xtract, access to which shall be restricted by Xtract to QIBs.

 

8.
Indemnity and Contribution.

 

(a)
The Company agrees to indemnify and hold harmless each Initial Purchaser, each person, if any, who controls any Initial Purchaser
within the meaning of either Section 15 of the Securities Act or Section 20 of the Exchange Act, and each affiliate of any Initial
Purchaser within the meaning of Rule 405 under the Securities Act from and against any and all losses, claims, damages and liabilities
(including, without limitation, any legal or other expenses reasonably incurred in connection with defending or investigating
any such action or claim) that arise out of, or are based upon, any untrue statement or alleged untrue statement of a material
fact contained in the Preliminary Memorandum, the Time of Sale Memorandum, any Additional Written Offering Communication prepared
by or on behalf of, used by, or referred to by the Company, any General Solicitation made by the Company, any “road show”
as defined in Rule 433(h) under the Securities Act (a “road show”), the Final Memorandum or any amendment or supplement
thereto, or arise out of, or are based upon, any omission or alleged omission to state therein a material fact required to be
stated therein or necessary to make the statements therein in light of the circumstances under which they were made not misleading,
except insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any such untrue statement or omission
or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to any Initial Purchaser
furnished to the Company in writing by such Initial Purchaser through the Representative expressly for use therein, it being understood
and agreed that the only such information furnished by the Initial Purchaser through the Representative consists of the information
described as such in paragraph (b) below.

 

(b)
Each Initial Purchaser agrees, severally and not jointly, to indemnify and hold harmless the Company, its directors, its officers
and each person, if any, who controls the Company within the meaning of either Section 15 of the Securities Act or Section 20
of the Exchange Act to the same extent as the foregoing indemnity from the Company to such Initial Purchaser, but only with reference
to information relating to such Initial Purchaser furnished to the Company in writing by such Initial Purchaser through the Representative
expressly for use in the Preliminary Memorandum, the Time of Sale Memorandum, any Additional Written Offering Communication set
forth in Schedule II hereto, road show, General Solicitation set forth in Schedule II hereto, the Final Memorandum or any amendment
or supplement thereto, it being understood and agreed that the only information furnished by any such Initial Purchaser consists
of the following information in the Final Memorandum furnished on behalf of each Initial Purchaser: (i) the first sentence of
the seventh paragraph of text under the caption “Plan of Distribution” concerning the terms of the offering by the
Initial Purchasers, and (ii) the first, fourth and fifth sentences of the twelfth paragraph of text under the caption “Plan
of Distribution” concerning stabilization.

 

    	26

    	 

    

 

(c)
In case any proceeding (including any governmental investigation) shall be instituted involving any person in respect of which
indemnity may be sought pursuant to Section 8(a) or 8(b), such person (the “indemnified party”) shall promptly
notify the person against whom such indemnity may be sought (the “indemnifying party”) in writing and the indemnifying
party, upon request of the indemnified party, shall retain counsel reasonably satisfactory to the indemnified party to represent
the indemnified party and any others the indemnifying party may designate in such proceeding and shall pay the reasonably incurred
and documented fees and disbursements of such counsel related to such proceeding. In any such proceeding, any indemnified party
shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such indemnified
party unless the indemnifying party and the indemnified party shall have mutually agreed in writing to the retention of such counsel
or the named parties to any such proceeding (including any impleaded parties) include both the indemnifying party and the indemnified
party and representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests
between them. It is understood that the indemnifying party shall not, in respect of the legal expenses of any indemnified party
in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the fees and expenses of more
than one separate firm (in addition to any local counsel) for all such indemnified parties and that all such fees and expenses
shall be reimbursed as they are incurred. Such firm shall be designated in writing by the Representative, in the case of parties
indemnified pursuant to Section 8(a), and by the Company, in the case of parties indemnified pursuant to Section 8(b). The indemnifying
party shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such
consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified party from
and against any loss or liability by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at any
time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses
of counsel as contemplated by the second and third sentences of this paragraph, the indemnifying party agrees that it shall be
liable for any settlement of any proceeding effected without its written consent if (i) such settlement is entered into more than
60 days after receipt by such indemnifying party of the aforesaid request and (ii) such indemnifying party shall not have reimbursed
the indemnified party in accordance with such request prior to the date of such settlement. No indemnifying party shall, without
the prior written consent of the indemnified party, effect any settlement of any pending or threatened proceeding in respect of
which any indemnified party is or could have been a party and indemnity could have been sought hereunder by such indemnified party,
unless such settlement (x) includes an unconditional release of such indemnified party from all liability on claims that are the
subject matter of such proceeding and (y) does not include a statement as to or an admission of fault, culpability or a failure
to act by or on behalf of any indemnified party.

 

    	27

    	 

    

 

(d)
To the extent the indemnification provided for in Section 8(a) or 8(b) is unavailable to an indemnified party or insufficient
in respect of any losses, claims, damages or liabilities referred to therein, then each indemnifying party under such paragraph,
in lieu of indemnifying such indemnified party thereunder, shall contribute to the amount paid or payable by such indemnified
party as a result of such losses, claims, damages or liabilities in such proportion as is appropriate to reflect the relative
benefits received by the indemnifying party or parties on the one hand and the indemnified party or parties on the other hand
from the offering of the Securities or if the allocation provided by clause 8(d)(i) above is not permitted by applicable law,
in such proportion as is appropriate to reflect not only the relative benefits referred to in clause 8(d)(i) above but also the
relative fault of the indemnifying party or parties on the one hand and of the indemnified party or parties on the other hand
in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other
relevant equitable considerations. The relative benefits received by the indemnifying party or parties on the one hand and the
indemnified party or parties on the other hand in connection with the offering of the Securities shall be deemed to be in the
same respective proportions as the net proceeds from the offering of the Securities (after deducting discounts and commissions
but before deducting expenses) received by the Company and the total discounts and commissions received by the Initial Purchasers,
bear to the aggregate offering price of the Securities. The relative fault of the indemnifying party or parties on the one hand
and the indemnified party or parties on the other hand shall be determined by reference to, among other things, whether the untrue
or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information
supplied by the Company or by the Initial Purchasers and the parties’ relative intent, knowledge, access to information
and opportunity to correct or prevent such statement or omission. The Initial Purchasers’ respective obligations to contribute
pursuant to this Section 8 are several in proportion to the respective principal amount of Securities they have purchased hereunder,
and not joint.

 

(e)
The Company and the Initial Purchasers agree that it would not be just or equitable if contribution pursuant to this Section 8
were determined by pro rata allocation (even if the Initial Purchasers were treated as one entity for such purpose) or
by any other method of allocation that does not take account of the equitable considerations referred to in Section 8(d). The
amount paid or payable by an indemnified party as a result of the losses, claims, damages and liabilities referred to in Section
8(d) shall be deemed to include, subject to the limitations set forth above, any legal or other expenses reasonably incurred by
such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the provisions
of this Section 8, no Initial Purchaser shall be required to contribute any amount in excess of the amount by which the total
price at which the Securities resold by it in the initial placement of such Securities were offered to investors exceeds the amount
of any damages that such Initial Purchaser has otherwise been required to pay by reason of such untrue or alleged untrue statement
or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the
Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The
remedies provided for in this Section 8 are not exclusive and shall not limit any rights or remedies which may otherwise be available
to any indemnified party at law or in equity.

 

    	28

    	 

    

 

(f)
The indemnity and contribution provisions contained in this Section 8 and the representations, warranties and other statements
of the Company contained in this Agreement shall remain operative and in full force and effect regardless of (i) any termination
of this Agreement, (ii) any investigation made by or on behalf of any Initial Purchaser, any person controlling any Initial Purchaser
or any affiliate of any Initial Purchaser or by or on behalf of the Company, its officers or directors or any person controlling
the Company (iii) and acceptance of and payment for any of the Securities.

 

9.
Termination. The Initial Purchasers may terminate this Agreement by notice given by the Representative to the Company,
if after the execution and delivery of this Agreement and prior to or on the Closing Date, or any Option Closing Date, as the
case may be, (i) trading generally shall have been suspended or materially limited on, or by, as the case may be, any of the New
York Stock Exchange, the Nasdaq Global Market, the Chicago Board of Options Exchange, the Chicago Mercantile Exchange or the Chicago
Board of Trade or other relevant exchanges, (ii) trading of any securities of the Company shall have been suspended on any exchange
or in any over-the-counter market, (iii) a material disruption in securities settlement, payment or clearance services in the
United States shall have occurred, (iv) any moratorium on commercial banking activities shall have been declared by Federal or
New York State authorities or (v) there shall have occurred any outbreak or escalation of hostilities, or any change in financial
markets or any calamity or crisis that, in the judgment of the Representative, is material and adverse and which, singly or together
with any other event specified in this clause (v), makes it, in the judgment of the Representative, impracticable or inadvisable
to proceed with the offer, sale or delivery of the Securities on the terms and in the manner contemplated in the Time of Sale
Memorandum or the Final Memorandum.

 

10.
Effectiveness; Defaulting Initial Purchasers. This Agreement shall become effective upon the execution and delivery hereof
by the parties hereto.

 

If,
on the Closing Date, or an Option Closing Date, as the case may be, any one or more of the Initial Purchasers shall fail or refuse
to purchase Securities that it or they have agreed to purchase hereunder on such date, and the aggregate principal amount of Securities
which such defaulting Initial Purchaser or Initial Purchasers agreed but failed or refused to purchase is not more than one-tenth
of the aggregate principal amount of Securities to be purchased on such date, the other Initial Purchasers shall be obligated
severally in the proportions that the principal amount of Firm Securities set forth opposite their respective names in Schedule
I bears to the aggregate principal amount of Firm Securities set forth opposite the names of all such non-defaulting Initial Purchasers,
or in such other proportions as the Representative may specify, to purchase the Securities which such defaulting Initial Purchaser
or Initial Purchasers agreed but failed or refused to purchase on such date; provided that in no event shall the principal
amount of Securities that any Initial Purchaser has agreed to purchase pursuant to this Agreement be increased pursuant to this
Section 10 by an amount in excess of one-ninth of such principal amount of Securities without the written consent of such Initial
Purchaser. If, on the Closing Date any Initial Purchaser or Initial Purchasers shall fail or refuse to purchase Firm Securities
which it or they have agreed to purchase hereunder on such date and the aggregate principal amount of Securities with respect
to which such default occurs is more than one-tenth of the aggregate principal amount of Firm Securities to be purchased on such
date, and arrangements satisfactory to the Representative and the Company for the purchase of such Firm Securities are not made
within 36 hours after such default, this Agreement shall terminate without liability on the part of any non-defaulting Initial
Purchaser or of the Company. In any such case either the Representative or the Company shall have the right to postpone the Closing
Date, but in no event for longer than seven days, in order that the required changes, if any, in the Time of Sale Memorandum,
the Final Memorandum or in any other documents or arrangements may be effected. If, on an Option Closing Date, any Initial Purchaser
or Initial Purchasers shall fail or refuse to purchase Additional Securities and the aggregate principal amount of Additional
Securities with respect to which such default occurs is more than one-tenth of the aggregate principal amount of Additional Securities
to be purchased on such Option Closing Date, the non-defaulting Initial Purchasers shall have the option to (a) terminate their
obligation hereunder to purchase the Additional Securities to be sold on such Option Closing Date or (b) purchase not less than
the principal amount of Additional Securities that such non-defaulting Initial Purchasers would have been obligated to purchase
in the absence of such default. Any action taken under this paragraph shall not relieve any defaulting Initial Purchaser from
liability in respect of any default of such Initial Purchaser under this Agreement.

 

    	29

    	 

    

 

If
this Agreement shall be terminated by the Initial Purchasers, or any of them, because of any failure or refusal on the part of
the Company to comply with the terms or to fulfill any of the conditions of this Agreement, or if for any reason the Company shall
be unable to perform its obligations under this Agreement, the Company will reimburse the Initial Purchasers or such Initial Purchasers
as have so terminated this Agreement with respect to themselves, severally, for all out-of-pocket expenses (including the fees
and disbursements of their counsel) reasonably incurred by such Initial Purchasers in connection with this Agreement or the offering
contemplated hereunder.

 

11.
Entire Agreement.

 

(a)
This Agreement, together with any contemporaneous written agreements and any prior written agreements (to the extent not superseded
by this Agreement) that relate to the offering of the Securities, represents the entire agreement between the Company and the
Initial Purchasers with respect to the preparation of the Preliminary Memorandum, the Time of Sale Memorandum, the Final Memorandum,
the conduct of the offering, and the purchase and sale of the Securities.

 

(b)
The Company acknowledges that in connection with the offering of the Securities: (i) the Initial Purchasers have acted at arms
length, are not agents of, and owe no fiduciary duties to, the Company or any other person, (ii) the Initial Purchasers owe the
Company only those duties and obligations set forth in this Agreement, any contemporaneous written agreements and prior written
agreements (to the extent not superseded by this Agreement) if any, and (iii) the Initial Purchasers may have interests that differ
from those of the Company. The Company waives to the full extent permitted by applicable law any claims it may have against the
Initial Purchasers arising from an alleged breach of fiduciary duty in connection with the offering of the Securities.

 

12.
Compliance with USA PATRIOT Act. In accordance with the requirements of the USA PATRIOT Act, the Initial Purchasers are
required to obtain, verify and record information that identifies their respective clients, including the Company, which information
may include the name and address of their respective clients, as well as other information that will allow the Initial Purchasers
to properly identify their respective clients.

 

13.
Recognition of the U.S. Special Resolution Regimes.

 

(a)
In the event that any Initial Purchaser that is a Covered Entity (as defined below) becomes subject to a proceeding under a U.S.
Special Resolution Regime, the transfer from such Initial Purchaser of this Agreement, and any interest and obligation in or under
this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime
if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United
States.

 

(b)
In the event that any Initial Purchaser that is a Covered Entity or a BHC Act Affiliate (as defined below) of such Initial Purchaser
becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights (as defined below) under this Agreement
that may be exercised against such Initial Purchaser are permitted to be exercised to no greater extent than such Default Rights
could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or
a state of the United States.

 

For
purposes of this Section a “BHC Act Affiliate” has the meaning assigned to the term “affiliate”
in, and shall be interpreted in accordance with, 12 U.S.C. § 1841(k). “Covered Entity” means any of the
following: (i) a “covered entity” as that term is defined in, and interpreted in accordance with, 12 C.F.R. §
252.82(b); (ii) a “covered bank” as that term is defined in, and interpreted in accordance with, 12 C.F.R. §
47.3(b); or (iii) a “covered FSI” as that term is defined in, and interpreted in accordance with, 12 C.F.R. §
382.2(b). “Default Right” has the meaning assigned to that term in, and shall be interpreted in accordance
with, 12 C.F.R. §§ 252.81, 47.2 or 382.1, as applicable. “U.S. Special Resolution Regime” means each
of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street
Reform and Consumer Protection Act and the regulations promulgated thereunder.

 

    	30

    	 

    

 

14.
Counterparts. This Agreement may be signed in counterparts, each of which shall be an original, with the same effect as
if the signatures thereto and hereto were upon and constitute one and the same instrument. Counterparts may be delivered via facsimile,
electronic mail (including any electronic signature complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions
Act or other applicable law, e.g., www. Docusign.com) or other transmission method any counterpart so delivered shall be deemed
to have been duly and validly delivered and be valid and effective for all purposes.

 

15.
Applicable Law. This Agreement and any claim, controversy or dispute relating to or arising out of this Agreement shall
be governed by and construed in accordance with the internal laws of the State of New York.

 

16.
Headings. The headings of the sections of this Agreement have been inserted for convenience of reference only and shall
not be deemed a part of this Agreement.

 

17.
Notices. All communications hereunder shall be in writing and effective only upon receipt and if to the Initial Purchasers
shall be delivered, mailed or sent to the Representative in care of Evercore Group L.L.C., 55 East 52nd Street, New York, New
York 10055, with a copy (which shall not constitute notice) to Cooley LLP, 500 Boylston Street, Boston, Massachusetts 02116, Attention:
Richard Segal; and if to the Company shall be delivered, mailed or sent to fuboTV Inc., 1330 Avenue of the Americas, New York,
New York, 10019, Attention: Gina Sheldon, with a copy (which shall not constitute notice) to Wilson Sonsini Goodrich & Rosati,
Professional Corporation, 650 Page Mill Road, Palo Alto, California 94304, Attention: Robert Day.

 

[Signature
Page Follows]

 

    	31

    	 

    

 

	 	Very truly yours,
	 	 	 
	 	FUBOTV INC.
	 	 	 
	 	By:	/s/
    Simone Nardi
	 	Name:	Simone
    Nardi
	 	Title:	CFO

 

	Accepted
    as of the date hereof	 
	 	 
	Evercore
    Group L.L.C.	 
	Acting
        on behalf of itself and the several Initial

        Purchasers
        named in Schedule I hereto.
	 
	 	 
	Evercore
    Group L.L.C.	 
	 	 
	By:	/s/
    Zaheed Kajani	 
	Name:	Zaheed
    Kajani	 
	Title:	Senior
    Managing Director	 

 

 [Signature
Page to Purchase Agreement]

 

    	 

    	 

    

 

Schedule
I

 

	Initial Purchaser	 	Principal Amount of Firm Securities to be Purchased	 
	 	 	 	 
	Evercore Group L.L.C.	 	$	350,000,000	 
	 	 	 		 
	Total:	 	$	350,000,000	 

 

    	I-1

    	 

    

 

Schedule
II

 

Permitted
Communications

 

Time
of Sale Memorandum

 

	1.	Preliminary
    Memorandum issued January 28, 2021
	 	 
	2.	Pricing
    term sheet dated January 28, 2021, attached hereto as Exhibit B

 

Permitted
Additional Written Offering Communications

 

	1.	Investor
    presentation dated January 28, 2021
	 	 
	2.	Pricing
    term sheet dated January 28, 2021, attached hereto as Exhibit B

 

Permitted
General Solicitations other than Permitted Additional Written Offering Communications set forth above

 

None

 

    	II-1

    	 

    

 

EXHIBIT
A

 

FORM
OF LOCK-UP AGREEMENT

 

Attached

 

    	 

    	 

    

 

FORM
OF LOCK-UP AGREEMENT

 

[          ],
2021

 

Evercore
Group L.L.C.

 

55
East 52nd Street

New
York, New York 10055

 

Ladies
and Gentlemen:

 

The
undersigned understands that Evercore Group L.L.C. (“Evercore”) propose to enter into a Purchase Agreement
(the “Purchase Agreement”) with FuboTV, Inc., a Florida corporation (the “Company”), providing
for the offering (the “Offering”) by the several Initial Purchasers (as defined in the Purchase Agreement),
including Evercore, of convertible senior notes of the Company (the “Securities”).

 

To
induce the Initial Purchasers that may participate in the Offering to continue their efforts in connection with the Offering,
the undersigned hereby agrees that, without the prior written consent of Evercore on behalf of the Initial Purchasers, the undersigned
will not, and will not publicly disclose an intention to, during the period commencing on the date hereof and ending 60 days after
the date of the final offering memorandum (the “Restricted Period”) relating to the Offering (the “Final
Memorandum”), (1) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option
or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly,
any shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), beneficially
owned (as such term is used in Rule 13d-3 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)),
by the undersigned or any other securities so owned convertible into or exercisable or exchangeable for Common Stock, (2) enter
into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership
of the Common Stock, or (3) engage in any hedging or other transaction designed or intended, or which could reasonably be expected
to lead to or result in, a sale or disposition of any shares of Common Stock, or securities convertible into or exercisable or
exchangeable for Common Stock, even if any such sale, disposition or other transaction would be made or executed by or on behalf
of someone other than the undersigned, whether any such transaction described in clause (1), (2) or (3) above is to be settled
by delivery of Common Stock or such other securities, in cash, or otherwise.

 

The
foregoing shall not apply to transfers of Common Stock:

 

(a)
by bona fide gift;

 

    	 

     

    

 

(b)
by will or other testamentary document or intestate succession to a Family Member (as defined below), legal representative,
heir or beneficiary, provided that any such transfer shall not involve a disposition for value;

 

(c)
to a trust whose beneficiaries consist exclusively of one or more of the undersigned and/or a Family Member;

 

(d)
solely by operation of law pursuant to a court order or divorce settlement agreement related to the distribution of assets in
connection with the dissolution of a marriage or civil union; or

 

(e)
to any corporation, partnership, limited liability company or other entity all of the beneficial ownership interests of which
are held by the undersigned or any Family Member of the undersigned; provided that any such transfer shall not involve
a disposition for value. In each case of the foregoing clauses (a) through (e), it shall be a condition to any such transfer
that:

 

(i)
transferee executes and delivers to Evercore an agreement in form and substance satisfactory to Evercore stating that such transferee
is receiving and holding such shares of Common Stock subject to the provisions of this agreement and agrees not to engage in any
other activity restricted under this agreement and will conduct its affairs in accordance with this agreement (as if such transferee
had been an original signatory hereto); and

 

(ii)
prior to the expiration of the Restricted Period, no public disclosure or filing under the Exchange Act by any party to the
transfer (including, without limitation, giftor, giftee, donor, donee, transferor or transferee) shall be required, or made
voluntarily, reporting a reduction in beneficial ownership of Common Stock in connection with such transfer, except in the
case of clause (d) above, in which case such transfer may be reported in a public disclosure or filing under the Exchange Act
or otherwise that is required to be made during the Restricted Period as a result of such transfer and which includes a
statement that such transfer has occurred by operation of law. Furthermore, notwithstanding the restrictions imposed by this
agreement, the undersigned may:

 

(A)
establish a trading plan pursuant to Rule 10b5-1 under the Exchange Act for the transfer of shares of Common Stock, provided that
such plan does not provide for any transfers of Common Stock during the Restricted Period and the entry into such plan is not
publicly disclosed, including in any filing under the Exchange Act, during the Restricted Period;

 

(B)
transfer shares of Common Stock under a trading plan pursuant to Rule 10b5-1 under the Exchange Act that is existing as of the
date hereof; provided that any filing required under Section 16(a) of the Exchange Act during the Restricted Period shall
state that such sales have been executed under a Rule 10b5-1 plan and shall also state the date such Rule 10b5-1 plan was adopted;

 

    	2

     

    

 

(C)
exchange shares of Series AA Preferred Stock for shares of Common Stock pursuant to a Company initiated tender offer; provided
that any shares of Common Stock acquired through such tender offer would be subject to the provisions of this agreement; and
provided further, that any filing required under Section 16(a) of the Exchange Act during the Restricted Period shall state
that such exchange was for shares of Common Stock made pursuant to a Company initiated tender offer and shall also state the date
such exchange was consummated;

 

(D)
if the undersigned is a corporation, partnership, limited liability company, trust or other business entity, transfer or distribute
Common Stock or any security convertible into or exercisable or exchangeable for Common Stock to current or former general or
limited partners, managers or members, stockholders, other equity holders or direct or indirect affiliates (within the meaning
of Rule 405 under the Securities Act of 1933, as amended) of the undersigned or to the estates of any of the foregoing; provided
that, in the case of any transfer or distribution pursuant to this clause (D), (x) each transferee or distributee shall sign
and deliver a lock-up agreement substantially in the form of this agreement, (y) no filing under the Exchange Act reporting a
reduction in beneficial ownership of shares of Common Stock shall be required or shall be voluntarily made during the Restricted
Period, and (z) such transfer shall not involve a disposition for value;

 

(E)
transfer or dispose of shares of Common Stock purchased by the undersigned on the open market following the Offering; provided
that no public disclosure or filing under the Exchange Act by any party to the transfer shall be required, or made voluntarily,
during the Restricted Period; and

 

    	3

     

    

 

(F)
transfer shares of Common Stock: (w) as forfeitures to the Company to satisfy tax withholding obligations of the undersigned in
connection with the vesting or exercise of equity awards pursuant to the Company’s equity incentive plan or outstanding
warrants by the undersigned, each as publicly disclosed and existing as of the date of the Purchase Agreement, provided that
any shares of Common Stock acquired in connection with such vesting or exercise of equity awards or warrants described in
this clause (w) shall be subject to the restrictions set forth in this agreement; (x) pursuant to a net exercise or cashless exercise
of outstanding equity awards pursuant to the Company’s equity incentive plan or outstanding warrants by the undersigned,
each as publicly disclosed and existing as of the date of the Purchase Agreement, provided that any shares of Common Stock
acquired upon the net exercise or cashless exercise of equity awards or warrants described in this clause (x) shall be subject
to the restrictions set forth in this agreement; (y) pursuant to a bona fide third-party tender offer approved by the Company’s
board of directors for all outstanding shares of the Company, merger, consolidation or other similar transaction made to all holders
of the Company’s securities involving a change of control of the Company (including, without limitation, the entering into
any lock-up, voting or similar agreement pursuant to which the undersigned may agree to transfer, sell, tender or otherwise dispose
of common stock or other such securities in connection with such transaction, or vote any common stock or other such securities
in favor of any such transaction), provided that in the event that such tender offer, merger, consolidation or other such
transaction is not completed, such securities held by the undersigned shall remain subject to the provisions of this agreement
(for purposes of this clause (y), “change of control” shall mean the transfer (whether by tender offer, merger, consolidation
or other similar transaction), in one transaction or a series of related transactions, to a person or group of affiliated persons,
of shares of capital stock if, after such transfer, such person or group of affiliated persons would become the beneficial owner
(as defined in Rules 13d-3 and 13d-5 of the Exchange Act) of more than 50% of the total voting power of the voting securities
of the Company (or the surviving entity)); or (z) that may be deemed to have occurred as a result of the cash exercise of an option
to purchase shares of Common Stock granted under any equity incentive plan or stock purchase plan of the Company or any outstanding
warrant to purchase shares of Common Stock, each as publicly disclosed and existing as of the date of the Purchase Agreement,
provided that any shares of Common Stock issued upon such exercise shall continue to be subject to the restrictions on
transfer set forth in this agreement; provided further, that, in the case of a transfer pursuant to clause (w),
(x) or (z) of this paragraph, no filing under the Exchange Act, reporting a reduction in beneficial ownership shall be required
or shall be voluntarily made during the Restricted Period.

 

For
purposes of this agreement, the term “Family Member” shall mean the spouse of the undersigned, an immediate
family member of the undersigned or an immediate family member of the undersigned’s spouse, in each case living in the undersigned’s
household or whose principal residence is the undersigned’s household (regardless of whether such spouse or family member
may at the time be living elsewhere due to educational activities, health care treatment, military service, temporary internship
or employment or otherwise). The term “immediate family member” as used above shall have the meaning set forth
in Rule 16a-1(e) under the Exchange Act.

 

The
undersigned agrees that, without the prior written consent of Evercore on behalf of the Initial Purchasers, it will not, during
the Restricted Period, make any demand for or exercise any right with respect to, the registration of any shares of Common Stock
or any security convertible into or exercisable or exchangeable for Common Stock.

 

The
undersigned also agrees and consents to the entry of stop transfer instructions with the Company’s transfer agent and registrar
against the transfer of the undersigned’s shares of Common Stock except in compliance with the foregoing restrictions.

 

The
undersigned understands that the Company and the Initial Purchasers are relying upon this agreement in proceeding toward consummation
of the Offering. The undersigned further understands that this agreement is irrevocable and shall be binding upon the undersigned’s
heirs, legal representatives, successors and assigns.

 

    	4

     

    

 

The
undersigned acknowledges and agrees that the Initial Purchasers have not provided any recommendation or investment advice nor
have the Initial Purchasers solicited any action from the undersigned with respect to the Offering of the Securities and the undersigned
has consulted its own legal, accounting, financial, regulatory and tax advisors to the extent deemed appropriate. The undersigned
further acknowledges and agrees that, although the Initial Purchasers may provide certain Regulation Best Interest and Form CRS
disclosures or other related documentation to you in connection with the Offering, the Initial Purchasers are not making a recommendation
to you to participate in the Offering or sell any Securities at the price determined in the Offering, and nothing set forth in
such disclosures or documentation is intended to suggest that any Initial Purchaser is making such a recommendation.

 

Whether
or not the Offering actually occurs depends on a number of factors, including market conditions. Any Offering will only be made
pursuant to a Purchase Agreement, the terms of which are subject to negotiation between the Company and the Initial Purchasers.

 

This
agreement shall automatically terminate and the undersigned will be released from all obligations hereunder upon the earliest
to occur, if any, of: (a) the Company, on the one hand, or Evercore, on the other hand, advising the other in writing that it
has determined not to proceed with the Offering prior to the execution of the Purchase Agreement; (b) the date that the Purchase
Agreement (other than provisions thereof that survive termination) is terminated, if prior to the closing of the Offering; and
(c) February 12, 2021, if the Purchase Agreement has not been executed by such date.

 

This
agreement shall be governed by and construed in accordance with the laws of the State of New York.

 

	 	Very
    truly yours,
	 	 
	 	 
	 	(Name)
	 	 
	 	 
	 	(Address)

 

    	5

     

    

 

EXHIBIT
B

 

PRICING
TERM SHEET

 

AttachedDocument

EXHIBIT 10.1

AMENDMENT NO. 1
TO
TAX RECEIVABLE AGREEMENT

    This Amendment No. 1 (this “Amendment”) is entered into as of December 31, 2020 (the “Effective Date”) by and among HLI, HLA and the Partners signatory hereto. Capitalized terms used but not otherwise defined herein shall have the meaning ascribed to them in the Agreement (as defined below).

WHEREAS, reference is made to the Tax Receivable Agreement (the “Agreement”) dated as of March 6, 2017, by and among Hamilton Lane Incorporated, a Delaware Corporation (“HLI”), Hamilton Lane Advisors, L.L.C., a Pennsylvania limited liability company (“HLA”) and each of the HLA Members.

WHEREAS, the Agreement may be amended in writing by HLI, HLA and the Partners (the “Supermajority Partners”) who would be entitled to receive at least two-thirds of the Early Termination Payments payable to all Partners under the Agreement if HLI had exercised its right of early termination under Section 4.01(a) of the Agreement on the date of the most recent Exchange prior to such amendment; and

WHEREAS, the parties hereto, including Partners sufficient to constitute the Supermajority Partners, have agreed to amend the Agreement as provided herein.

NOW, THEREFORE, in consideration of the mutual covenants and undertakings contained herein and for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the parties hereto hereby agree as follows:

1.The following defined terms appearing in Article I of the Agreement are hereby amended and restated in their respective entireties to read as follows:

    “Agreed Rate” means SOFR plus 100 basis points.

    “Default Rate” means SOFR plus 500 basis points.

    “Early Termination Rate” means the lesser of (i) 7.5% and (ii) SOFR plus 400 basis points.

2.The defined term “LIBOR” appearing in Article I of the Agreement is hereby removed in its entirety.

3.The following defined terms are hereby added to Article I of the Agreement immediately following the definition of “Share of Liabilities” and immediately preceding the definition of “Specified Partner”:

    “SOFR” means, with respect to any Business Day, a rate per annum equal to the secured    overnight financing rate for such Business Day published by the SOFR Administrator on    the SOFR Administrator’s Website on the immediately succeeding Business Day, or, if such rate is unavailable or otherwise unacceptable to HLI, such other rate as may be selected in HLI’s reasonable discretion.

    “SOFR Administrator” means the Federal Reserve Bank of New York (or a successor    administrator of the secured overnight financing rate).

    “SOFR Administrator Website” means the website of the Federal Reserve Bank of New    York, currently at http://www.newyorkfed.org, or any successor source for the secured     overnight financing rate identified as such by the SOFR Administrator from time to time.

4.Except as explicitly modified by Sections 1, 2 and 3 above, the other provisions, terms and conditions of the Agreement are and will remain in full force and effect. On and after the Effective Date, each reference in the Agreement to “this Agreement,” “the Agreement,” “hereunder,” “hereof,” “herein,” or words of like import, and each reference to the Agreement in any other agreements, documents, or instruments executed and delivered pursuant to, or in connection with, the Agreement, will mean and be a reference to the Agreement as amended by this Amendment.

5.This Amendment may be executed in one or more counterparts, all of which shall be considered one and the same agreement and shall become effective when one or more counterparts have been signed by each of the parties and delivered to the other parties, it being understood that all parties need not sign the same counterpart. Delivery of an executed signature page to this Amendment by facsimile or email transmission shall be as effective as delivery of a manually signed counterpart of this Amendment.

6.This Amendment shall be governed by, and construed in accordance with, the law of the Commonwealth of Pennsylvania (and, to the extent applicable, federal law), without regard to the conflicts of laws principles thereof that would mandate the application of the laws of another jurisdiction.

7.If any term or other provision of this Amendment is invalid, illegal or incapable of being enforced by any law or public policy, all other terms and provisions of this Amendment shall nevertheless remain in full force and effect so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Amendment so as to effect the original intent of the parties as closely as possible in an acceptable manner in order that the transactions contemplated hereby are consummated as originally contemplated to the greatest extent possible.

*    *    *

IN WITNESS WHEREOF, the undersigned have caused this Amendment No. 1 to be duly executed and delivered as of the date first set forth above.
                    
						
	HAMILTON LANE INCORPORATED
	 	 
	By:	/s/ Atul Varma
	 	Name: Atul Varma
	 	Title: Chief Financial Officer
	 	 
	HAMILTON LANE ADVISORS, L.L.C.
	 	 
	By:	/s/ Atul Varma
	 	Name: Atul Varma
	 	Title: Chief Financial Officer
	 	 
	HLA INVESTMENTS, LLC
	By:	HRHLA, LLC, its managing member
		
	By:	/s/ Hartley R. Rogers
	 	Name: Hartley R. Rogers
	 	Title: Manager
	 	 
	HRHLA, LLC
		
	By:	/s/ Hartley R. Rogers

		Name: Hartley R. Rogers
		Title: Manager
	
	HAMILTON LANE ADVISORS, INC.
	 	 
	By:	/s/ Mario L. Giannini
	 	Name: Mario L. Giannini
	 	Title: President
	 	 

			
	/s/ Mario L. Giannini
	 Mario L. Giannini

			
	/s/ Erik R. Hirsch
	 Erik R. Hirsch

						
	The 2008 Sexton Des. Trust FBO Matthew Sexton
		
	By:	/s/ O. Griffith Sexton
	 	Name: O. Griffith Sexton
	 	Title: Trustee

						
	The 2008 Sexton Des. Trust FBO Laura Sexton
		
	By:	/s/ O. Griffith Sexton
	 	Name: O. Griffith Sexton
	 	Title: Trustee

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}]]